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1.1 PSEUDORABIES VIRUS 
1.1.1 Introduction 
Pseudorabies virus (PRV), a swine pathogen also known as Suid Herpesvirus 1 (SHV-1) or 
Aujeszky’s disease virus, is a member of the Herpesviridae family. All herpesviruses share 
common biological characteristics such as a double-stranded DNA genome, comparable 
size (200 to 250 nm) and structure (envelope, tegument and capsid), and undergo a 
latent stage at some point during their life cycle, ensuring long-term survival of the virus 
in the host population. 
The Herpesviridae family (including viruses of mammal, bird and reptile), along with two 
other families - Alloherpesviridae (containing fish and frog viruses) 
and Malacoherpesviridae (containing a bivalve virus) - belongs to the Herpesvirales 
order. The Herpesviridae family can be further divided in three subfamilies: 
Alphaherpesvirinae, Betaherpesvirinae and Gammaherpesvirinae (Davison et al., 2009). 
Subdivision of the family is based on biological criteria, genome characteristics and virus 
structure. For example, the three subfamilies differ with regard to the length of their 
productive replication cycle and typically establish latency in different cell types: 
neurons for most of the Alphaherpesvirinae, the monocyte lineage for the 
Betaherpesvirinae and lymphocytes for the Gammaherpesvirinae (Arvin et al., 2007). 
PRV is classified as an alphaherpesvirus, and like several other members of this 
subfamily, PRV is able to infect different species and replicate rapidly, generating new 
viral particles in a matter of hours. Human alphaherpesviruses include the human herpes 
simplex virus 1 and 2 (HSV-1, HSV-2) and varicella zoster virus (VZV). Besides PRV, there 
are other widely studied animal alphaherpesviruses, like bovine herpesvirus 1 and 5 
(BoHV-1, BoHV-5), equine herpesvirus 1 and 4 (EHV1, EHV-4), canine herpesvirus 1 (CHV-
1) and feline herpesvirus (FHV-1). The chicken herpesvirus Marek’s Disease virus (MDV) 
is also classified as an alphaherpesvirus, although it establishes latency in T lymphocytes 
(Calnek et al., 1984a; Calnek et al., 1984b; Shek et al., 1983; Spencer and Calnek, 1970). 
To some, the focus in virology entails the search for solutions of practical problems. (…) 
To others, virology offers the opportunity to study fundamental problems in biology 
(Lynn Enquist, in Life beyond eradication: veterinary viruses in basic science). In addition 
to being instrumental in the eradication of the pathogen in several industrialized 
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countries, PRV research has provided valuable and general insights in the 
alphaherpesvirus life cycle and the complex virus-host interactions. Therefore, PRV 
remains of major interest to virologists for several reasons: PRV has a broad host range, 
being able to cause (lethal) infection in different animals, but it poses no threat to 
humans; this virus is easy to manipulate and grows well in culture; purified DNA is 
infectious, and the techniques to replace and manipulate its genes are thoroughly 
described; bacterial artificial chromosomes encoding the entire viral genome have been 
constructed (Kopp et al., 2003; Smith and Enquist, 1999; Smith and Enquist, 2000); and 
finally, animal experiments can be carried out in the natural host of PRV, the pig, as well 
as in other animal models, such as mice, rats and rabbits.  
 
1.1.2 Structure 
The complete genome of PRV (± 144 kbp) has been entirely sequenced (Klupp et al., 
2004; Szpara et al., 2011) and is similar in arrangement to other alphaherpesviruses, 
containing a unique long segment (UL) and a unique short region (US). The US region is 
flanked by inverted repeat sequences, resulting in the formation of two possible PRV 
genome isomers with oppositely oriented US regions. Designation of the different genes 
depends on their position on the different regions, UL or US, and on their place within 
the specific region, represented by a number. The PRV genome contains 72 open reading 
frames (ORF) and encodes 70 different proteins, and all of these proteins have orthologs 
in other alphaherpesviruses (Klupp et al., 2004; Pomeranz et al., 2005).  
The virion architecture of PRV resembles others in the Herpesviridae family. The mature 
virion consists of four distinct structural components: a DNA genome in its central core, 
a protective capsid enclosing the genome, the tegument and a lipid envelope (Figure 1). 
Together, the linear double-stranded DNA genome and the icosahedral capsid (formed 
by 162 capsomers) compose the nucleocapsid (Mettenleiter, 2000; Newcomb et al., 
1999). The nucleocapsid is surrounded by a protein matrix known as the tegument, 
which contains proteins that are important for viral entry and morphogenesis 
(Mettenleiter, 2002).
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A                                                                                               B 
 
Figure 1. A Schematic representation of the PRV virion. B Transmission electron microscopic picture of 
the PRV virion (Granzow et al., 1997). 
 
Finally, the tegument is surrounded by the envelope, a double phospholipid membrane 
embedded with several viral (glyco)proteins (gB, gC, gD, gE, gH, gI, gK, gL, gM, gN, UL20, 
UL43, US9). The envelope is acquired by budding of the capsid in vesicles derived from 
the trans-Golgi network (Mettenleiter and Minson, 2006; Mettenleiter et al., 2006). The 
envelope proteins play essential or important roles in viral entry, egress, cell-to-cell 
spread, induction of protective immunity and immune evasion (reviewed in (Nauwynck 
et al., 2007; Pomeranz et al., 2005)).  
 
1.1.3 Infection cycle 
Figure 2 offers an overview of the virus productive replication cycle, which can be 
roughly subdivided into 5 stages: (1) virus attachment and entry, (2) transport of the 
nucleocapsid to the nucleus, (3) gene expression, (4) replication and virus assembly and 
(5) egress. The following information is mostly based on the replication cycle of HSV, the 
prototype of the Alphaherpesvirinae subfamily. Information that is specific for the PRV 
replication cycle will be indicated as such in the text. 
 


















Figure 2. Replication cycle of PRV. Virions attach to (1) and subsequently fuse (2) with the plasma membrane. Capsids are released in the cytoplasm and transported 
along microtubules to the nucleus (3), where viral DNA is released into the nucleus (4). After DNA replication (5) and capsid assembly (6), DNA is packaged into the 
preformed capsids (7). Capsids bud into the inner nuclear membrane (8) and primary enveloped virus particles are found in the perinuclear space (9). The primary 
envelope is lost during fusion with the outer nuclear membrane (10). Subsequently, a secondary envelope is acquired by budding into the trans-Golgi network (11). 
Virus particles are released (13) by fusion with the plasma membrane (12) (adapted from (Mettenleiter, 2004). IET/P: immediate-early transcription/proteins; ET/P: 
early transcription/proteins; LT/P: late transcription/proteins.
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Entry 
Attachment of the virion to the plasma membrane is divided into two steps: a first labile 
interaction of gC (and, to a lesser extent, gB) with heparan sulfate proteoglycans in the 
cell membrane, followed by a more stable interaction between gD and specific cellular 
receptors, stabilizing the virion-cell interaction. The first binding, although non-
essential, greatly enhances the efficiency of infection (Immergluck et al., 1998; Karger 
et al., 1995; Mettenleiter et al., 1990; Shukla and Spear, 2001; Spear and Longnecker, 
2003). With regard to the second and more stable binding, three classes of gD-
associated receptors have been identified (Spear et al., 2000): (i) HVEM (herpesvirus 
entry mediator), a member of the TNF receptor family; (ii) nectins and nectin-like 
molecules (nectin 1, nectin 2 and poliovirus receptor (PVR, CD155)), members of the 
immunoglobulin super family; and (iii) specific heparan sulfate moieties generated by 
certain 3-O-sulfotransferases (Geraghty et al., 1998; Heldwein and Krummenacher, 
2008; Montgomery et al., 1996; Shukla et al., 1999; Warner et al., 1998). 
Alphaherpesviruses differ in their affinity for the different described receptors. HSV-1 
and HSV-2 share their preference for HVEM and nectin-1; concerning the other two 
receptors, only HSV-2 makes use of nectin-2 for entry (although it has a weak activity), 
while HSV-1 favours 3-O-sulphate-modified heparan sulfate. In the case of PRV, three 
entry receptors have been described so far: nectin-1, nectin-2 and PVR (Campadelli-
Fiume et al., 2000; Spear and Longnecker, 2003; Spear et al., 2000). 
However, it has been reported that nectin-1, despite binding to gD, is not necessary for 
PRV entry in fibroblasts (Ch’ng et al., 2007). For HSV-1 and PRV, gB was also shown to 
interact with receptors like paired immunoglobulin-like type 2 receptor alpha (PILRα) 
(Arii et al., 2009; Satoh et al., 2008) and non-muscle myosin heavy chain IIA (NMHC-IIA) 
(Arii et al., 2010; Arii et al., 2015).  Interaction between gB and NMHC-IIB has been 
described for HSV-1 (Arii et al., 2010). 
Following virus binding to host cells, the viral envelope fuses with the plasma 
membrane, a process that requires four viral proteins: gB, gD, gH and gL (Atanasiu et al., 
2010; Fan et al., 2015; Klupp et al., 1997; Rauh and Mettenleiter, 1991). These 
glycoproteins are absolutely essential for viral entry, as depletion of either one of them 
abrogates viral entry (Klupp et al., 1997; Mata et al., 2001; Peeters et al., 1992; Rauh and 
Mettenleiter, 1991; Reske et al., 2007; Subramanian et al., 2007). Depending on the cell 
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type, the virus may also enter the cell via endocytosis, although it remains unclear how 
the virus selects its entry pathway (Clement et al., 2006; Frampton et al., 2005; Gianni 
et al., 2004; Hambleton et al., 2007; Komala Sari et al., 2013; Nicola and Straus, 2004; 
Nicola et al., 2003; Nicola et al., 2005) . 
 
Transport to the nucleus 
Upon arrival in the cytoplasm, incoming nucleocapsids are rapidly transported through 
the cytosol towards the nuclear pore complexes, where the viral genomes are injected 
into the nucleoplasm. Evidence indicates that the tegument proteins UL36 (also known 
as VP1/2) and UL37 are essential for transport of the capsid to the nucleus. To propel 
the capsids from the periphery to the nucleus, the virus travels along microtubules via 
an interaction with dynein (Antinone and Smith, 2010; Dodding and Way, 2011; 
Granzow et al., 2005; Luxton et al., 2005; Luxton et al., 2006; Sodeik et al., 1997), a 
cellular microtubule-associated motor protein. UL36 has been found to associate with 
dynein, thereby acting as a potent effector of microtubule-dependent transport 
(Zaichick et al., 2013). UL36 was also reported to play a role in docking of the 
nucleocapsid at the nuclear pores and release of the viral genome in the nucleus 
(Copeland et al., 2009; Jovasevic et al., 2008). UL37 has been shown to be required for 
rapid nuclear translocation (Krautwald et al., 2009). Also, a more recent study reported 
dystonin/BPAG1, an important cytoskeleton cross-linker involved in microtubule-based 
transport, as a binding partner of the HSV-1 UL37 protein (Pasdeloup et al., 2013). 
 
Gene expression  
After injection into the nucleus, the genome circularizes and the transcription cascade 
starts, a process that is tightly regulated (Ben-Porat and Kaplan, 1985). At a first stage, 
the virus uses the host cell machinery to transcribe the immediate-early (IE) genes. For 
PRV, only one IE gene has been reported so far, IE180, which is homologous to HSV-1 
ICP4 (Cheung, 1989; Vlček et al., 1989).The IE180 protein is a transactivator and drives 
the expression of several viral genes, including US4 (gG), UL12 (alkaline nuclease), UL22 
(gH), UL23 (thymidine kinase) and UL41 (viral host shutoff). The early genes are 
subsequently transcribed and translated, and their protein products often regulate 
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expression of cellular and viral promotors (EP0, UL48, UL54) and produce protein 
determinants for nucleotide synthesis (UL23, UL39/UL40, UL50) and DNA replication 
(UL5, UL9, UL30, UL42, UL52) (Berthomme et al., 1995; Fuchs et al., 2002; Jöns et al., 
1997; Kaliman et al., 1994; Kit et al., 1987; Lehman and Boehmer, 1999; Ono et al., 1998; 
Schwartz et al., 2006). Finally, transcription of late genes, which for the most part 
encode structural proteins, is prompted by DNA replication (Ben-Porat and Kaplan, 
1985). 
 
Replication and assembly  
DNA replication is initiated by circularization of the linear viral genome, proceeding 
towards a rolling-circle mechanism of replication. This process produces replicated DNA 
in the form of long linear concatemeric genomes that serve as the substrate for genome 
encapsidation. The newly formed capsid proteins enter the nucleus for assembly of the 
progeny capsids (Copeland et al., 2009). Encapsidation of PRV DNA requires two linked 
events: cleavage of the replicated concatemeric DNA into monomeric units and 
packaging of the linear monomeric genomes into capsids, by pulling the genome 
through a cylindrical entry pore encoded by the protein UL6 (Ben-Porat and Kaplan, 




Most enveloped viruses assemble their capsids in the cytoplasm, acquiring their 
envelope later by budding at the plasma membrane or at cytoplasmic membranes. Since 
nucleocapsids are assembled in the nucleus, herpesviruses first have to face the 
challenge of transporting their capsids across the nuclear envelope. They achieve this 
via a peculiar two-step process, consisting of envelopment at the inner nuclear 
membrane (INM) (Hofemeister and O’Hare, 2008), leaving a virion with a primary 
envelope in the perinuclear space between both nuclear membranes. This is followed 
by fusion of the primary envelope with the outer nuclear membrane (ONM), releasing 
the naked capsid in the cytoplasm. Very few enveloped particles are observed in the 
perinuclear space, suggesting that this process occurs quickly and efficiently 
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(Mettenleiter, 2002; Skepper et al., 2001). Three proteins (US3, UL31, and UL34) have 
been reported to contribute to this ‘nuclear escape process’ (Funk et al., 2015; Lorenz 
et al., 2015; Paßvogel et al., 2014, 31; Reynolds et al., 2002; Reynolds et al., 2004; Schulz 
et al., 2014; Schumacher et al., 2005; Sherry et al., 2017; Simpson-Holley et al., 2004).  
Once in the cytoplasm, tegument proteins start to interact with the capsid, which is then 
directed to the site of secondary envelopment, (vesicles derived from) the trans-Golgi 
network (TGN). At this stage, the different envelope proteins are already expressed in 
the membrane of the TGN. It is likely that an intricate interaction between tegument 
proteins, capsid and envelope proteins aid the tegumented capsid to bud in the TGN 
(Granzow et al., 1997; Mettenleiter et al., 2006). This process confers the virion its 
envelope, although this secondary envelopment is still poorly understood. Several viral 
envelope and tegument proteins have been linked to this process, including UL11, gE/gI, 
gD, gM, and more recently UL36 and UL37 (Baines and Roizman, 1992; Brack et al., 2000; 
Fulmer et al., 2007; Kelly et al., 2014; Kopp et al., 2003; Kopp et al., 2004; Leege et al., 
2009). For PRV, gE/gI and gM were proven to be particularly important, since double-
deletion of gE (or its cytoplasmic region alone) and gM largely impaired secondary 
envelopment (Brack et al., 2000).  
In a final step, infectious particles are then released via exocytosis (Granzow et al., 1997; 
Granzow et al., 2001). Hogue and co-workers have visualized the final transport and 
exocytosis of PRV particles using a live-cell microscopy-based method. In short, virus 
particles travel to the plasma membrane inside small, acidified secretory vesicles which 
undergo fast, directional transport directly to the site of exocytosis. Vesicles are tightly 
docked at the site of exocytosis for several seconds, and membrane fusion occurs, 
displacing the virion a small distance across the plasma membrane. After exocytosis, 
particles remain tightly confined on the outer cell surface (Hogue et al., 2014). 
  
1.1.4 Intercellular spread 
Spread of herpesviruses may occur via two distinct routes: cell-free dissemination and 
cell-to-cell or cell-associated spread. Cell-free dissemination enables the virus to transit 
rapidly through the blood, lymph and cerebrospinal fluid to infect distant tissues. 
However, by exiting the cell to infect another cell or host, viral particles are exposed to 
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various biophysical, kinetic and immunological barriers. Typically, cell-to-cell spread is 
rapid and efficient, partly due to viruses and their cell surface receptors being in close 
proximity. Also, when moving across the narrow spaces between cells, the viral particles 
are protected from the effects of neutralizing antibodies and other immune system 
components by cell junctions. Still, whether the virion is released to diffuse and infect 
new host cells, or spread directly between adjacent cells, depends on the target cell or 
tissue (Mothes et al., 2010; Sattentau, 2008; Zhong et al., 2013). 
The simplest mechanism of cell-associated spread consists of the fusion of infected and 
uninfected cells, resulting in giant multinuclear cells (syncytium). Alphaherpesviruses 
induce syncytium formation in vitro and in vivo (Cole and Grose, 2003; Spear, 1993), and 
express a range of glycoproteins that have a role in this process. Cell–cell fusion by HSV-
1 requires the coordinated action of glycoproteins gB, gD and gH–gL on the virus-
infected cell, with a further role for the gD receptor on the target cell (Campadelli-Fiume 
et al., 2007; Reske et al., 2007).  
There are other, more sophisticated, mechanisms of cell-to-cell virus spread used by 
alphaherpesviruses, like transfer of virions across neuronal synapses and direct viral 
spread across cell junctions. Viral spread between unconnected cells through formation 
of viral-induced projections which connect distant cells has also been described. These 
mechanisms are explained more in detail below.  
PRV and HSV-1 infection lead to formation of varicosities (synaptic boutons) in sensory 
neurons of the trigeminal ganglion and rat hippocampal neurons, respectively. These 
varicosities form synaptic contacts which appear to be sites for cell-to-cell transmission 
to surrounding neuronal and non-neuronal cells. In both viruses, the formation of 
varicosities is driven by gD and its receptor nectin-1 (De Regge et al., 2006; Mizoguchi et 
al., 2002), suggesting a possible role for gD in promoting cell-associated spread from 
neurons to neighbouring cells. Nevertheless, for PRV (but not HSV), this glycoprotein is 
not absolutely essential for neuronal cell-to-cell spread (Ch’ng et al., 2007; Peeters et 
al., 1992; Rauh and Mettenleiter, 1991).  
Alphaherpesviruses are also able to spread across cell junctions. The glycoprotein E plays 
an important part in this process (Johnson et al., 2001a; Zsak et al., 1992), and as this 
glycoprotein is one of the key subjects of this thesis, this topic will be discussed in detail 
later, 
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The highly conserved viral US3 protein kinase also plays a role in efficient viral spread. 
This protein is responsible for the formation of long actin- and microtubule-containing 
cellular projections, which can connect otherwise unconnected nearby cells. The virus 
was found to move across these filaments, being able to successfully infect neighbouring 
uninfected cells, even in the presence of virus-neutralizing antibodies (Favoreel et al., 
2005). 
 
1.1.5 Pathogenesis  
Pigs are the natural host of PRV. These animals are able to survive PRV infection whilst 
most mammals (with the exception of higher primates and humans that are non-
susceptible) succumb to the virus. Severity of infection can vary, depending on virus 
strain-specific virulence as well as on the age and immunological status of the animal. In 
neonatal piglets, PRV causes severe to fatal affliction of the nervous system, whereas 
older pigs typically suffer from relatively mild respiratory complications, like coughing, 
sneezing and pneumonia. Pregnant sows may suffer from reproductive failure upon 
infection, including abortion, stillbirths and mummified foetuses. 
PRV reaches sensory neurons via the respiratory tract, which is the primary site of 
infection upon oronasal infection (Pomeranz et al., 2005). Initial replication in 
respiratory epithelia is followed by infection of neurons and depends on the essential 
entry glycoproteins gB, gD and gH–gL (Mettenleiter, 2003). Upon entry in nerve cells, 
the virus is transported by retrograde traffic towards the cell body of the sensory 
neurons, where it replicates in the nucleus and/or becomes latent. Specific stimuli, 
which are often stress-related, may trigger reactivation of the virus and virus 
dissemination through anterograde axonal transport (Kramer and Enquist, 2013; 
Tomishima et al., 2001). The virus may also spread via the blood and lymph, allowing it 
to reach and replicate in other internal organs, like reproductive organs (Pomeranz et 
al., 2005).
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1.2. THE GLYCOPROTEIN E OF PSEUDORABIES VIRUS 
1.2.1 Introduction 
The glycoprotein E of pseudorabies virus (gE, initially called gI) was first characterized in 
1984 by Hampl and coworkers. This glycoprotein is an envelope protein and can be 
divided in three distinct domains: a 428-amino-acid N terminal (extracellular domain), a 
26-amino-acid hydrophobic transmembrane domain, and a 123-amino-acid, highly 
charged C terminal (cytoplasmic domain) (Figure 3) (Tirabassi et al., 1997).  
Homologs of PRV gE can be found in all alphaherpesviruses. Although there is little 
amino acid identity between the homologous proteins, two clusters (one at the N-
terminal and one at the C-terminal end) of closely spaced cysteine residues can be found 
in PRV, HSV-1, bovine herpesvirus type 1 (BHV-1), EHV-1, VZV, and other 
alphaherpesviruses. Whilst the cluster at the N-terminal region is only partly conserved 
in some alphaherpesviruses, the cysteine cluster at the C-terminal region, consisting of 
five cysteine residues, is extremely well conserved in all members of this subfamily 
(reviewed in Jacobs, 1994).  
Shortly after protein translation, gE binds to another glycoprotein, the glycoprotein I (gI, 
initially called gp63). Both gE and gI are transmembrane proteins that form a 
heterodimer in the endoplasmic reticulum (ER) via noncovalent interactions between 
their ectodomains and the complex is often referred to as one functional entity 
(Tirabassi et al., 1997; Whealy et al., 1993; Zuckermann et al., 1988). The formation of 
this heterodimer facilitates the maturation and intracellular transport of both proteins 
to the plasma membrane of cells (Whealy et al., 1993; Zuckermann et al., 1988). 
Nevertheless, PRV gE and gI can reach the cell surface independently of each other, 
albeit with lower efficiency (Tirabassi and Enquist, 1998; Whealy et al., 1993). Some 
studies have also shown that PRV gE appear to have a bigger impact in the function of 
the heterodimer: deletion of the gene encoding PRV gE caused the virus to be less 
virulent and spread with lower efficiency than gI-negative virus (Jacobs, 1994; Kimman 
et al., 1992; Kritas et al., 1994; Kritas et al., 1995). The absence of gE also caused a more 
severe decrease in antibody-induced capping observed in infected cells (Favoreel et al., 
1997). Therefore, without disregarding the contribution /importance of gI, this thesis 
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will focus mainly on gE, although it is implied that some of the functions discussed 
further are common to (or depend on) both gE and gI. 
After leaving the ER, PRV gE localizes primarily to the Golgi apparatus, cytoplasmic 
vesicles and the plasma membrane (Tirabassi and Enquist, 1998; Tirabassi et al., 1997). 
Labeling of cell surface proteins either with biotin or using specific antibodies 
demonstrated that gE undergoes constitutive endocytosis up until 6 hours post infection 
(Tirabassi and Enquist, 1998). Endocytosis of gE depends on its cytoplasmic domain, 
which contains several potential endocytosis/trafficking motifs: two tyrosine-based 
YXXΦ motifs (a membrane proximal at amino acid positions 478–481 and another at 
amino acid positions 517-510), clusters of acidic residues, and dileucine motifs (LL) 
(Alconada et al., 1996; Alconada et al., 1999; Fölsch et al., 1999; Tirabassi and Enquist, 
1999; Zhu et al., 1996). The YXXΦ and LL motifs may interact with μ and β subunits of 
clathrin adapters (Le Borgne and Hoflack, 1998; Molloy et al., 1999) and these 
interactions might affect intracellular trafficking in endosomes and the trans-Golgi 
Network (TGN), as well as endocytosis. In addition, such motifs also determine 
basolateral versus apical sorting in polarized cells (Bonifacino and Dell’Angelica, 1999; 
Brideau et al., 2000; Fölsch et al., 1999; Tirabassi and Enquist, 1999). Both HSV-1 and 
VZV gE contain similar tyrosine-based motifs within their cytoplasmic domains that are 
important for endocytosis and sorting (Brideau et al., 2000). The endocytosis motifs in 
PRV gE do not appear to contribute to the efficiency of gE incorporation in the envelope 
of progeny virions (Tirabassi and Enquist, 1999). Despite several studies on the topic, 
the exact role of endocytosis of gE during infection is yet to be fully understood.  
 
1.2.2 Functions of PRV gE  
Glycoprotein E is not essential for replication (in vitro or in vivo) of either PRV or other 
alphaherpesviruses, like HSV-1 (Longnecker and Roizman, 1986; Neidhardt et al., 1987), 
EHV-1 (Flowers and O’Callaghan, 1992) and BHV-1 (Engelenburg et al., 1995; Jacobs, 
1994). The only exception is VZV. This virus does not express gD, which is essential in 
most other alphaherpesviruses, and VZV gE appears to take over the function of gD, 
being vital for viral entry (Cohen and Nguyen, 1997; Moffat et al., 2002). On the other 
hand, conservation of gE among the different Alphaherpesvirinae subfamily members 
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strongly indicates that this protein may be essential for virus survival in the host 
population. The functions of PRV gE have been studied for many years and several roles 
have been described for this glycoprotein. Most notably, gE is involved in mediating full 
virulence in animal infections and cell-to-cell spread. Other functions like virion 
assembly (mentioned above) and species-specific binding of immunoglobulin G (IgG) 
through its Fcγ receptor-like activity have also been reported. Later in this chapter we 
describe these functions with greater detail (Figure 3). 
 
Figure 3. Representation of the different domains of the glycoprotein gE: N terminal (extracellular 
domain) = 428 aa; transmembrane domain (TMD) = 26 aa; C terminal (cytoplasmic domain) = 123 aa. The 




Early reports on the characterization of PRV gE showed that this viral protein is a 
determinant factor for PRV’s virulence (Card and Enquist, 1995; Card et al., 1992; Jacobs 
et al., 1993b; Jacobs et al., 1993b; Kimman et al., 1992; Lomniczi et al., 1984; 
Mettenleiter et al., 1987). Virulence is usually quantified by the time after infection 
when symptoms begin to appear or by the mean time to the animal’s death. Animals, 
both pigs and mice, infected with PRV gEnull mutants live longer, develop symptoms 
later, and are symptomatic for a significantly shorter time than are animals infected with 
wild-type virus (Card and Enquist, 1995; Jacobs, 1994; Jacobs et al., 1993b; Kritas et al., 
1994; Kritas et al., 1995; Tirabassi et al., 1997). Different studies suggested that, in the 
absence of gE, the transport of the virus to certain parts of the nervous system is 
impaired to some extent (Jacobs, 1994; Jacobs et al., 1993b; Kimman et al., 1992; Kritas 
et al., 1994; Kritas et al., 1995; Tirabassi and Enquist, 1999; Tirabassi et al., 1997). 
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Deletion of the gene encoding HSV-1 gE drastically decreased neurovirulence in mice 
(Meignier et al., 1988); also, gE-negative BHV-1 mutants were avirulent in calves 
(Kaashoek et al., 1994).  
Impaired virulence of PRV in the absence of gE has been attributed, at least partially, to 
the reduced ability of these viruses to spread from cell to cell and from neuron to neuron 
(discussed later in this chapter) (Card et al., 1992; Kimman et al., 1992; Mettenleiter et 
al., 1987; Whealy et al., 1993). However, several data have shown that gE-mediated 
virulence and spread appear to reflect two possibly independent functions. For example, 
the attenuated PRV vaccine strain, Bartha, which lacks gE amongst other proteins, 
spreads remarkably well in the central nervous system (CNS) (Card and Enquist, 1995; 
Card et al., 1990; Rinaman et al., 1993). Despite this, when infected with the Bartha 
strain, pigs remain symptom free, and mice live several days longer than wild-type virus-
infected animals (Rinaman et al., 1993). Similarly, in the rodent eye infection model, 
gEnull viruses are not completely defective in neuronal spread, even though these 
mutants appear to be less virulent (Card et al., 1992; Whealy et al., 1993). Tirabassi et 
al. have shown that the cytoplasmic domain of PRV gE is necessary for full virulence, but 
not for neurotropism in the rat eye model, suggesting that virulence and neurotropism 
defects seen in infection with gE mutants may indeed reflect separate functions 
(Tirabassi and Enquist, 1998; Tirabassi and Enquist, 1999; Tirabassi et al., 1997). 
Considering all the reports mentioned above, it is evident that PRV gE greatly influences 
virulence, although the underlying mechanisms are not entirely clear.  
 
Viral spread  
HSV and PRV cell-to-cell spread mediated by gE has been observed primarily or 
exclusively in polarized cells or in cells that form extensive junctions with one another 
(i.e., keratinocytes, epithelial cells, and neurons) (Dingwell and Johnson, 1998; Dingwell 
et al., 1995; Enquist et al., 1998; Mettenleiter et al., 1987; Tirabassi and Enquist, 1998; 
Wisner et al., 2000; Zsak et al., 1992). In experimental animal models, both HSV and PRV 
mutants lacking gE are restricted for spread in epithelial tissues and in the nervous 
system (Card et al., 1992; Dingwell et al., 1994; Dingwell et al., 1995; Tirabassi and 
Enquist, 1998; Tirabassi and Enquist, 1999). In cell culture, infection with PRV gE mutant 
viruses results in smaller plaques, emphasizing the role of this protein during cell-to-cell 
Chapter 1 - Introduction 
16 
spread. Other studies have confirmed these findings for HSV and VZV (Cohen and 
Nguyen, 1997; Cole and Grose, 2003; Dingwell et al., 1994; Jacobs et al., 1993a; Jacobs 
et al., 1993b; Johnson and Huber, 2002; Johnson et al., 2001a; Tirabassi and Enquist, 
1998). In addition, deletion of the cytoplasmic domain of gE resulted in a similar small 
plaque phenotype, suggesting that this domain may be involved in gE-mediated viral 
spread (Tirabassi et al., 1997; Tirabassi and Enquist, 1999). However, as mentioned 
above, PRV mutants lacking the cytoplasmic region of gE were shown to be able to 
spread in the rat CNS (Tirabassi et al., 1997; Tirabassi and Enquist, 1999). 
PRV mutants lacking gE also showed reduced anterograde neuronal spread in vitro 
(Ch’ng and Enquist, 2005a; Ch’ng and Enquist, 2005b). The importance of gE in cell-to-
cell spread in non-neuronal cells and anterograde spread in neurons has been 
thoroughly studied, and it is not clear if these two phenotypes reflect common or 
distinct mechanisms. 
Regarding gE-mediated cell-to-cell spread in polarized epithelial cells, Johnson and 
Huber proposed a model based on various observations (Figure 4). Briefly, gE 
accumulates in the TGN/endosomes, which promotes accumulation of other viral 
components (glycoproteins and tegument) in the same compartments. This 
accumulation and ultimate acquisition of the viral envelope occurs in specific 
TGN/endosome membranes that will then be sorted specifically to the basolateral 
surfaces. These processes depend on the interaction between the cytoplasmic domain 
of gE and the AP-1 cellular sorting machinery (specifically μ1B, a component of the AP-
1 clathrin adapter complexes). As virus replication continues, there is directed delivery 
of nascent particles to cell junctions; virus particles are delivered into the space between 
adjacent cells and can initiate infection of a neighbouring cell (Brack et al., 2000; 
Farnsworth and Johnson, 2006; Granzow et al., 2001; Harley et al., 2001; Johnson and 
Huber, 2002; Johnson et al., 2001a; McMillan and Johnson, 2001).





Figure 4. gE mediates directed egress in polarized epithelial cells, facilitating cell-to-cell virus spread 
(adapted from Johnson and Huber, 2002). gE accumulates in the TGN/endosomes, promoting aggregation 
of other viral components. The interaction between gE and the AP-1 cellular sorting machinery is 
important for directing nascent virions to lateral cell surfaces 
 
Furthermore, the authors speculated that not only the cytoplasmic domain, but also the 
extracellular domain of gE might play a role in cell-to-cell spread, perhaps by binding to 
proteins that are components of cell junctions, e.g., cell adhesion molecules (Dingwell 
and Johnson, 1998; Johnson and Huber, 2002; McMillan and Johnson, 2001). This may 
explain the preferential localization of gE to cell junctions (McMillan and Johnson, 2001; 
Wisner et al., 2000).  
The role of gE in anterograde spread in neurons has been further elucidated more 
recently, although the mechanism is still far from being fully comprehended. 
Kratchmarov et al. suggested that gE is required for efficient anterograde transport of 
viral particles by indirectly facilitating or stabilizing the interaction between US9 and the 
kinesin-3 motor KIF1A, a cellular motor protein that mediates axonal movement of viral 
particles (Kratchmarov et al., 2013). Another viral envelope protein, US9 has been 
shown to be essential for initial sorting of virions to axons, although the subsequent step 
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of fast axonal transport is carried out independently from this viral protein (Daniel et al., 
2015). 
 
 Virion assembly 
As mentioned above, gE accumulates in the TGN and endosomes, which may contribute 
to virion assembly in these organelles. PRV mutants lacking both gE, or its cytoplasmic 
domain, and gM caused the accumulation of large numbers of cytosolic nucleocapsids 
(Brack et al., 2000). This is consistent with a role for gE and gM in secondary 
envelopment of virus particles. These and other data have led to the hypothesis that gE 
promotes the initial accumulation of virus structural components in the TGN or 
endosomes, likely in tandem with other virion components, such as gM, which 
contributes to secondary envelopment of progeny virus particles (Brack et al., 2000; 
Granzow et al., 2001; McIntosh and Smith, 1996). 
  
Fcγ receptor-like activity and cell signalling  
Similar as described for HSV and VZV, PRV gE has been shown to exhibit IgG binding 
(Favoreel et al., 1997; Johnson et al., 1988; Litwin et al., 1992). This Fcγ receptor-like 
activity of gE was shown to be involved in viral immune evasion, both in HSV and PRV 
(Nagashunmugam et al., 1998; Van de Walle et al., 2003a), probably by shielding the Fc 
domain of virus-specific antibodies from immune effectors like complement, NK cells 
and phagocytes.  
Adding PRV-specific antibodies to PRV-infected epithelial cells resulted in antibody-
antigen capping characterized by the polarization of viral glycoproteins and associated 
antibodies on the surface of an infected cell. This capping process was mediated by gE 
(Favoreel et al., 1999). Similar antibody-induced and gE-mediated capping of viral 
glycoproteins was also reported for HSV (Rizvi and Raghavan, 2003) . Although the exact 
function of gE-mediated antibody-antigen capping is not entirely clear, it resembles 
capping of immunoreceptors on leukocytes. The latter process is observed upon 
crosslinking of immunoreceptors with antibodies or antigens, and typically leads to 
leukocyte activation (D’Ambrosio et al., 1996). The cytoplasmic domain of gE was 
reported to take part in this capping, since deleting the cytoplasmic domain of gE 
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strongly reduced the phenomenon, and since capping was associated with Src tyrosine 
kinase-mediated tyrosine phosphorylation of the cytoplasmic domain of gE 
(Desplanques et al., 2007; Favoreel et al., 1999). Mutation of the YXXΦ motifs in the 
cytoplasmic domain of gE reduced tyrosine phosphorylation of gE and suppressed 
antibody-induced capping (Desplanques et al., 2007; Favoreel et al., 1999). These YXXΦ 
motifs resemble immunoreceptor tyrosine-based motifs (ITAM) found in the 
cytoplasmic region of immunoreceptors. ITAM domains are crucial for antigen-induced 
signalling and activation of immune cells. Furthermore, it was reported that gE 
associates with lipid rafts, that this lipid raft association increases during capping, and 
that gE-mediated capping may depend on lipid raft-associated signalling machinery, as 
disruption of these structures inhibits capping, which again shows strong similarity to 
the mechanism of immune receptor signalling and capping during leukocyte activation 
(Desplanques et al., 2007; Favoreel et al., 2004). Taken together, these studies suggest 
that gE, in addition to its Fcγ receptor-like activity, may also trigger cell signalling in the 
infected cell. However, gE-mediated effects on particular cell signalling pathways have 
not been directly demonstrated thus far.  
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1.3. MITOGEN-ACTIVATED PROTEIN KINASES (MAPK) 
1.3.1 Introduction 
Cells respond to their surroundings in a highly efficient manner, translating extracellular 
messages into an appropriate cellular response. Such outside-in communication usually 
begins with the interaction between extracellular stimuli (like mitogens or hormones) 
and specific molecules present on the cell membrane, which subsequently transmit the 
different signals through the signalling network of the cell. These signalling processes, 
or signalling pathways, may also be modulated by pathogens. 
Over the years, numerous intracellular signalling pathways have been identified, 
including the mitogen-activated protein kinase (MAPK) signalling pathways that are at 
the heart of many signalling networks (Ahn, 1993; Bogoyevitch and Court, 2004; Chang 
and Karin, 2001; Johnson and Lapadat, 2002; Pearson et al., 2001; Seger and Krebs, 
1995). The MAPK signalling pathways consist of several tiers of protein kinases that 
sequentially activate each other by phosphorylation and each tier is composed of several 
isoforms. This increases the complexity of the signalling pathways, conferring a broader 
range of activity and specificity to the MAPK system. The MAPK signalling cascades are 
often referred to as the central building blocks of the intracellular signalling network, as 
they regulate a diversity of cellular processes like proliferation, differentiation, 
migration, development, stress response, and apoptosis (Bogoyevitch and Court, 2004; 
Kuida and Boucher, 2004; Raman and Cobb, 2003; Rubinfeld and Seger, 2005).  
The four MAPK cascades currently known are named according to the subgroup of their 
MAPK components: (1) extracellular signal-regulated kinase 1 and 2 (ERK1/2) (Boulton 
et al., 1991; Sturgill and Ray, 1986); (2) c-Jun N-terminal kinase (JNK), also known as 
stress-activated protein kinase 1 (SAPK1)(Dérijard et al., 1994; Kyriakis et al., 1994); (3) 
p38 MAPK, also known as SAPK2-4 or p38 α−δ (Freshney et al., 1994; Han et al., 1994; 
Rouse et al., 1994); and (4) ERK5, also known as Big MAPK (BMK) (Lee et al., 1995; Zhou 
et al., 1995).  
The distinct MAPK pathways differ in their physiological activities: ERK1/2 in general 
plays a role in cell survival, proliferation and differentiation, whilst JNK and p38 are often 
involved in stress responses and apoptosis. The ERK5 cascade seems to transmit both 
mitogenic and stress signals. However, there are many exceptions to these broad 
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function subdivisions and specific MAPK-dependent functions may be cell type- and cell 
condition-dependent. For example, ERK1/2 signalling has also been reported to 
participate in apoptotic responses under certain conditions (as described later in this 
chapter), whereas JNK signalling may take a part in cell survival and proliferation (Hess 
et al., 2002). Despite their distinct physiological activity, cross-talk between the MAPK 
different signalling pathways often occurs and contributes to the ultimate fate of the 
cell in response to different stimuli (Junttila et al., 2008). 
This thesis will focus on one particular branch of the MAPK signalling cascade, the 
ERK1/2 pathway, which controls a myriad of cellular events, making it a very attractive 
target for various pathogens, including viruses.  
 
1.3.2 The ERK1/2 signalling pathway 
The ERK1/2 signalling pathway was the first of the MAPK system to be elucidated 
(Boulton et al., 1991; Seger and Krebs, 1995; Sturgill and Ray, 1986). This signalling 
pathway is evolutionary conserved and is involved in the control of many fundamental 
cellular processes that include cell proliferation, survival, differentiation, apoptosis, 
motility, metabolism, morphology determination and oncogenic transformation (Chong 
et al., 2003; O’Neill and Kolch, 2004; Seger and Krebs, 1995; Torii et al., 2004; Viala and 
Pouysségur, 2004; Wellbrock et al., 2004; Yoon and Seger, 2006).  
Two ERK genes have been described for mammals and these genes encode a 44 kDa 
protein (ERK1) and a 42 kDa protein (ERK2) (Boulton et al., 1991; Seger and Krebs, 1995; 
Sturgill and Ray, 1986). Because of the high degree of similarity between ERK1 and ERK2, 
these proteins are considered to be functionally redundant and are mostly being 
referred to as ERK1/2, although some differences in their substrate specificity have been 
reported (Seger and Krebs, 1995).  
Figure 5 depicts a general overview of the ERK1/2 signalling pathway. 
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Figure 5.  The MAPK/ERK1/2 signalling pathway. The first pathway of the MAPK system to be elucidated, 
this signalling cascade is composed by several tiers of protein kinases that sequentially activate each other 
by phosphorylation, controlling many fundamental cellular processes. P – Phosphoryl group. 
 
ERK1/2 can be activated by a wide variety of extracellular agents, which include growth 
factors, hormones, and neurotransmitters (Chang et al., 2003; Chuderland and Seger, 
2005; Yao and Seger, 2004; Zhang and Liu, 2002). These extracellular factors, acting 
through several receptors like G protein-coupled receptors (Naor et al., 2000), tyrosine 
kinase receptors (Marmor et al., 2004) and ion channels (Rane, 1999), initiate a variety 
of intracellular downstream events. The ERK1/2 signalling cascade is usually triggered 
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by the activation of small G proteins (e.g. Ras), which transmit the signal further to the 
next tier of the cascade, composed of MAPK kinase kinases (MAP3K) (Ahn, 1993). The 
three isoforms of the Raf kinase family (A-Raf, B-Raf and Raf-1) are considered to be the 
primary MAP3K for ERK1/2 activation, although additional MAP3K (MOS, MEKK1 and 
TLP2) may also lead to ERK1/2 phosphorylation under more restricted cell type- and 
stimulation-specific situations (Gotoh and Nishida, 1995; Lange-Carter et al., 1993; 
Raman et al., 2007; Salmeron et al., 1996). All these MAP3K transmit the signal further 
by phosphorylating and activating the MAPK kinase tier composed of MAPK/ERK kinases 
(MEK1/2; (Ahn et al., 1991; Gómez and Cohen, 1991). MEK1/2 is a dual-specificity 
protein kinase that mediates the phosphorylation of tyrosine as well as threonine 
residues in ERK1/2, its only known physiological substrate (Payne et al., 1991; Ray and 
Sturgill, 1988; Roskoski Jr., 2012; Seger et al., 1992). 
ERK1/2 is a ubiquitous serine/threonine kinase and due to the broad nature of its 
substrate recognition, ERK1/2 can phosphorylate numerous proteins (Yoon and Seger, 
2006). Some of these proteins are localized in the cytoplasm, whilst others are 
phosphorylated in the nucleus after nuclear translocation of activated ERK1/2 (Yoon and 
Seger, 2006). Notably, ERK1/2 activates a series of transcription factors such as Elk1 
(Gille et al., 1992), c-Fos (Murphy et al., 2002), p53 (Milne et al., 1994), Ets1/2 (Yang et 
al., 1996), and c-Jun (Morton et al., 2003), which are important for the initiation and 
regulation of proliferation and oncogenic transformation. Alternatively, ERK1/2 may 
activate the family of MAP Kinase Activated Protein Kinases (MAPKAPKs). The main 
MAPKAPK activated by ERK1/2 is the 90 kDa ribosomal S6 kinase, RSK (Sturgill et al., 
1988), which can translocate independently into the nucleus where it phosphorylates a 
set of transcription factors, playing its own role in transcriptional regulation. Additional 
MAPKAPKs are the mitogen- and stress-activated kinases (MSK; (Deak et al., 1998)) and 
the MAPK-interacting kinases (MNKs; (Fukunaga and Hunter, 1997; Waskiewicz et al., 
1997), which are equally activated by the related p38 MAPK cascade (Kant et al., 2003). 
All the above substrates change their activity upon phosphorylation by ERK1/2, and may 
contribute to ERK1/2-dependent processes.  
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1.3.3 Regulation of the ERK1/2 signalling pathway 
The ERK1/2 signalling cascade is able to activate different, sometimes opposing, 
processes within the same cell. This raises the question how the cell regulates this 
signalling pathway in order to guarantee a specific effect. Several parameters that 
determine the signalling outcome have been proposed in the past years. Duration and 
strength of ERK1/2 phosphorylation is one of these factors (Ebisuya et al., 2005; 
Marshall, 1995; Murphy and Blenis, 2006). Several studies investigating ERK1/2 
activation have shown that transient ERK1/2 activation leads to different effects than 
sustained activation (Ebisuya et al., 2005; Kolch, 2005; Marshall, 1995). As a classical 
example, in rat PC12 cells, transient Ras-dependent activation of the ERK1/2 signalling 
pathway by Epidermal Growth Factor (EGF) induces proliferation, whilst sustained 
ERK1/2 activation by Nerve Growth Factor (NGF) induces differentiation (Dumaz and 
Marais, 2005; Gotoh and Nishida, 1995; Marshall, 1995; Murphy et al., 2002; Nguyen et 
al., 1993; York et al., 1998). York et al. have reported that transient and sustained ERK 
activation in PC12 cells are regulated by the small GTPases Ras and Rap1, respectively 
(Sasagawa et al., 2005; York et al., 1998). Duration of ERK1/2 activation can also be 
influenced by protein kinase C (PKC)/Raf signalling  (Bhalla and Iyengar, 1999; Bhalla et 
al., 2002). Another temporal regulator of ERK activity is Sprouty – a negative feedback 
inhibitor of the ERK pathway (Hanafusa et al., 2002). Overexpression of Sprouty led to a 
transient ERK1/2 activation, suppressing the differentiation of PC12 cells. In contrast, 
overexpression of a dominant-negative form of Sprouty results in sustained ERK1/2 
activation and promotes PC12 cells differentiation. 
The strength of ERK1/2 activity is also a determinant of cell fate. The regulation of the 
magnitude of ERK1/2 signalling can be carried out by scaffold proteins, such as KSR 
(kinase suppressor of Ras) and MP1 (MEK partner 1). KSR interacts with Raf, MEK and 
ERK, thereby potentiating ERK activation  (McKay et al., 2009; Morrison, 2001; Therrien 
et al., 1996). KSR forms a ternary complex with MEK and ERK and the absence of KSR 
significantly diminishes MAPK signalling (Nguyen et al., 2002). MP1 facilitates coupling 
of ERK to MEK (Schaeffer et al., 1998), and reduction of MP1 expression results in 
decreased ERK activation in response to growth factor stimulation (Teis et al., 2002). 
Subcellular localization of ERK1/2 also plays a role in its regulation (Ebisuya et al., 2005; 
Kolch, 2005; Pouysségur et al., 2002), leading to different protein-protein interactions 
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and therefore defining which substrates will be activated. Translocation of ERK1/2 to 
the nucleus allows its access to several transcription factors, like Elk-1, Sap-1a, and TIF-
IA (Chen et al., 1992; Gille et al., 1992; Lenormand et al., 1993; Zhao et al., 2003). On the 
other hand, cytosolic ERK1/2 may phosphorylate different substrates such as pro-
apoptotic Bim, and MLCK and m-calpain, two pro-migration proteins. Interaction with 
various scaffold proteins appears to regulate spatial distribution of ERK1/2 (Chuderland 
and Seger, 2005; Ebisuya et al., 2005; Kolch, 2005; Morrison and Davis, 2003). Proteins 
like β-arrestin-2, PEA-15 (phosphoprotein enriched in astrocytes) and Sef bind to 
ERK1/2, which blocks its translocation to the nucleus (Formstecher et al., 2001; Torii et 
al., 2004; Whitehurst et al., 2004). Sef resides on the Golgi apparatus and binds active 
MEK/ERK complexes, permitting signalling to cytosolic substrates but not nuclear targets 
(Torii et al., 2004). PEA-15 binds ERK1/2, abolishes its nuclear translocation, and thereby 
inhibits the phosphorylation of Elk-1. Also, PEA-15 contains a nuclear export sequence 
that mediates the relocation of ERK1/2 from the nucleus to the cytoplasm (Formstecher 
et al., 2001). A similar regulatory mechanism is mediated by β-arrestin-2, as this adaptor 
protein also contains a nuclear export sequence. Thus, ERK1/2 activation caused by β-
arrestin-2-mediated assembly of complexes comprising Raf-1, MEK and ERK/MAPK is 
majorly restricted to the cytoplasm (DeFea et al., 2000; Luttrell et al., 2001; Tohgo et al., 
2003; Wei et al., 2003). 
Other elements contribute to the regulation of ERK1/2 signalling, including extensive 
cross-talk and interplay with other intracellular signalling pathways (Dumaz and Marais, 
2005; Raman and Cobb, 2003), and the presence of several similar but functionally 
different isoforms in each tier of the cascade (Lloyd, 2006), including alternatively 
spliced forms (Aebersold et al., 2004). In addition, the particular ERK1/2-dependent 
effect of a given ligand on different cells may also be influenced by other mechanisms, 
such as the cell type-specific expression of ERK1/2 substrates (Yoon and Seger, 2006). 
Another layer of ERK1/2 regulation complexity is generated by the many phosphatases 
that can downregulate ERK1/2 activity (Krishna and Narang, 2008; Muthumani et al., 
2005; Wang et al., 2006). Once dephosphorylated in the nucleus, ERK1/2 is rapidly 
exported to the cytosol via an active mechanism that is mediated, at least in part, by 
MEK which enters the nucleus independently from ERK1/2 (Adachi et al., 2000). 
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1.3.4 The role of ERK1/2 activation in different cellular processes  
As mentioned above, the ERK1/2 signalling pathway is involved in a broad range of 
different cellular processes. To keep the extensive information within the scope of this 
thesis, only the cellular processes that are of particular relevance for the current work 
were selected for a more detailed description in the present chapter, namely cell 
motility and cell survival. 
 
ERK1/2 in cell motility  
The process of cell migration involves a continuous cycle of adhesion and detachment 
(adhesion turnover) both at the leading edge and the rear end of cells (Ridley et al., 
2003; Webb et al., 2002). The ERK1/2 signalling pathway has been reported to regulate 
different stages in the process of cell motility. As consequence, inhibition of the ERK1/2 
signalling pathway prevents the migration of diverse cell types in response to various 
stimuli (Anand-Apte et al., 1997; Cheresh et al., 1999; Cuevas et al., 2003; Degryse et al., 
2001; Eliceiri et al., 1998; Jo et al., 2002; Klemke et al., 1997; Krueger et al., 2001; Lai et 
al., 2001; Nguyen et al., 1999; Shono et al., 2001; Webb et al., 2000; Xie et al., 1998). 
Several ERK1/2 substrates, including various protein kinases, transcription factors and 
nuclear proteins have been linked to cell migration (Deak et al., 1998; Fukunaga and 
Hunter, 1997; Glading et al., 2004; Hunger-Glaser et al., 2003; Klemke et al., 1997; 
Waskiewicz et al., 1997). The focal adhesion kinase (FAK)/paxillin complex, the myosin 
light chain kinase (MLCK) and calpains are the most likely candidates to be involved in 
ERK1/2-mediated cell migration (Figure 6). 




















Figure 6.  The role of the ERK1/2 signalling pathway in cell motility. The ERK1/2 signalling pathway can 
regulate different stages in the process of cell motility by phosphorylating different substrates that have 
been shown to be important for cell motility. ERK1/2 substrates, focal adhesion kinase (FAK)/paxillin 
complex, the myosin light chain kinase (MLCK) and calpains, were reported to mediate key events in 
cellular motility such as focal adhesion formation, adhesion turn-over and lamellipodium extension. P – 
Phosphoryl group. 
 
FAK is a non-receptor protein tyrosine kinase that localizes at focal adhesions or focal 
contacts (Schaller, 2001a). FAK mediates the phosphorylation of paxillin, a well-known 
scaffolding molecule (Bellis et al., 1995; Schaller, 2001b), that can recruit other 
molecules to focal adhesions and regulate the organization of the actin cytoskeleton. 
FAK and paxillin have been found to be critical for cell spreading and migration 
(Deramaudt et al., 2014; Lai et al., 2000; Liu et al., 2002) and the interaction between 
these two proteins is involved in focal adhesion turnover (Webb et al., 2004), although 
the precise role and mechanism remain to be fully clarified. It has been shown that 
ERK1/2 activity mediates phosphorylation of both FAK and paxillin, as well as regulating 
the association of FAK with paxillin (Hunger-Glaser et al., 2003; Ishibe et al., 2004; Jiang 
et al., 2007). Phosphorylation of paxillin by ERK1/2 has been shown to enhance the FAK-
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paxilin association (Liu et al., 2002), whereas ERK1/2-mediated phosphorylation of FAK 
at Ser910 was shown to block the interaction of FAK with paxillin (Hunger-Glaser et al., 
2003). These intriguing observations may suggest a sophisticated regulation of the FAK-
paxillin complex, in which ERK1/2 might initially promote complex-assembly by 
phosphorylation of paxillin and then promote disassembly by subsequent 
phosphorylation of FAK, leading to inactivation of the latter, promoting adhesion 
turnover and cellular migration (Zheng et al., 2009).  
MLCK controls actin-myosin contractility through the phosphorylation of myosin light 
chain (MLC). Phosphorylation of MLC allows the formation of a functional actin-myosin 
motor. Interestingly, MLC phosphorylation by MLCK occurs at the leading edge of 
migrating cells, suggesting an important role for MLCK in the control of lamellipodium 
extension (Mitchison and Cramer, 1996; Totsukawa et al., 2004). In this context, it was 
shown that ERK1/2 directly phosphorylates and activates MLCK, leading to MLC 
phosphorylation and cell migration (Klemke et al., 1997; Mansfield et al., 2000; Nguyen 
et al., 1999; Webb et al., 2004).  
Calpains are a family of Ca2+-activated proteolytic enzymes that are involved in cell 
migration (Dourdin et al., 2001; Huttenlocher et al., 1997). ERK1/2 phosphorylates m-
calpain both in vitro and in vivo, and phosphorylation of m-calpain is required for 
adhesion turnover and cell migration (Glading et al., 2004). However, the exact 
molecular mechanism of regulation of motility by ERK1/2 and calpain remains to be 
determined.   
It is also well known that the Ras-Raf-MEK-ERK pathway regulates the affinity of 
integrins for their substrate (Chou et al., 2003; Hughes et al., 1997), although the 
molecular mechanism remains to be elucidated. Because dynamic integrin activation is 
required for cell migration (Chou et al., 2003; Huttenlocher et al., 1996; Palecek et al., 
1997), ERK1/2 might also play an important role in the regulation of cell migration by 
modulating integrin activity (Ishibe et al., 2003). 
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ERK1/2 and cell survival  
ERK1/2 activation has generally been associated with cell survival and proliferation. 
Nonetheless, a number of studies have shown that depending on the stimuli and cell 
types involved, activation of ERK1/2 can also mediate cell death. Some studies suggest 
that the balance between the intensity and duration of pro- versus anti-apoptotic signals 
mediated by the ERK1/2 cascade determines whether a cell survives and proliferates or 
undergoes apoptosis (Ebisuya et al., 2005; Lu and Xu, 2006; Pearson et al., 2001; Shaul 
and Seger, 2007). However, the molecular mechanisms that define the conditions for 
ERK1/2-mediated cell death remain poorly understood.  
The ERK1/2 signalling pathway modulates cell survival by different mechanisms like 
post-translational modification and regulation of components of the cell death 
machinery, and controlled transcription of anti- and pro-survival genes (Figure 7) (Kolch, 
2005).  
As mentioned earlier in this chapter, ERK1/2 activates the RSK (ribosomal S6 family 
kinases) kinase family. This kinase family is usually present in the cytoplasm in quiescent 
cells (Anjum and Blenis, 2008; Zhao et al., 1996) and catalyses the phosphorylation and 
subsequent degradation of the pro-apoptotic Bcl-2 family member protein Bad. 
Furthermore, the pro-apoptotic BH-3 only protein Bim, another member of the Bcl-2 
family, is phosphorylated on multiple sites by ERK1/2 and targeted for poly-
ubiquitination, followed by degradation via the proteasome pathway (Ewings et al., 
2007; Hübner et al., 2008; Ley et al., 2003). These and other studies have shown that 
phosphorylation and degradation of Bim and/or Bad by ERK1/2 through multiple 
mechanisms can contribute to reduced sensitivity of cells to apoptosis (Bonni et al., 
1999; Ley et al., 2003; Sheridan et al., 2008; Zha et al., 1996a). Evidence of repressed 
activation of more downstream events, such as inhibition of caspase activity, has also 
been reported. ERK1/2 has been shown to phosphorylate, and consequently inhibit, 
caspase 9, blocking subsequent downstream events, such as caspase 3 activation, 
culminating in inhibition of cell death (Allan et al., 2003). 




Figure 7.  The role of the ERK1/2 signalling pathway in promoting cell survival. The ERK1/2 signalling 
pathway modulates cell survival by different mechanisms like post-translational modification and 
regulation of components of the cell death machinery, and controlled transcription of anti- and pro-
survival genes. ERK1/2 triggers phosphorylation of apoptosis mediators, like Bcl-2 family members Bad 
and Bim, as well as Caspase 9, leading to the degradation of these proteins and protection against 
apoptosis. Additionally, ERK1/2 potentiates the activity of pro-survival proteins Mcl-1 and IEX-1. ERK1/2 
also interferes with transcription factors like STAT3/5 and CREB to promote cell survival. P – Phosphoryl 
group. 
 
In addition to suppressing the functions of pro-apoptotic proteins, ERK1/2 can promote 
cell survival by enhancing the activity of anti-apoptotic molecules. Mcl-1, an anti-
apoptotic member of the Bcl-2 family, is phosphorylated by ERK1/2, thus increasing its 
stability and enhancing its anti-apoptotic activity (Domina et al., 2004). ERK1/2-
mediated activation of IEX-1, an early response and nuclear factor kappa B (NF-kB) target 
gene, leads to prevention of cytochrome c release from the mitochondria and to 
inhibition of cell death induced by various stimuli (Garcia et al., 2002).  
ERK1/2 may also control cell survival by regulating the activity of anti- and pro-apoptotic 
transcription factors. ERK1/2-activated RSK phosphorylates the transcription factor 
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cAMP response element-binding protein (CREB) (Bonni et al., 1999), which allows 
recruitment of the co-activators CREB-binding protein (CBP) and p300, strongly 
enhancing CREB-dependent transcription (Janknecht and Nordheim, 1996; Johannessen 
et al., 2004). Activated CREB promotes cell survival, and inhibition of CREB 
phosphorylation triggers neuronal apoptosis (Bonni et al., 1999). In addition, it has been 
also shown that inhibition of ERK1/2 upregulates STAT3/5 phosphorylation and 
promotes cell apoptosis (Krasilnikov et al., 2003).  
Despite the progress in identifying the mechanisms that control ERK1/2-mediated cell 
survival and proliferation, as indicated, there is also convincing but poorly understood 
evidence supporting a role for the MEK-ERK signalling cassette in cell death (Mebratu 
and Tesfaigzi, 2009). Additional studies are required to define which conditions allow 
ERK1/2 activation to be responsible for both cell survival/proliferation and apoptosis. 
The complexity of the ERK1/2 signalling network undoubtedly contributes to this 
proliferation/apoptosis conundrum, and likely depends on particular yet to be identified 
cell type- and stimulus-dependent ERK1/2 substrates and regulators.  
 
1.3.5 Herpesviruses interaction with the ERK1/2 signalling 
cascade 
As mentioned above, the ERK1/2 signalling pathway is involved in an impressive array of 
different cellular processes, making it highly attractive for viruses to manipulate this 
signalling cascade for their own benefit. Many different viruses have been reported to 
modulate (and often activate) the ERK1/2 signalling cascade. In addition, for some 
viruses, multiple viral proteins belonging to the same virus trigger this signalling 
pathway. One good example is the human immunodeficiency virus 1 (HIV-1). Several 
groups have shown that ERK1/2 activation is required for HIV replication (Hemonnot et 
al., 2004; Mettling et al., 2008; Yang and Gabuzda, 1999) and at least three HIV-1 viral 
proteins have been shown to trigger ERK1/2 signalling, Nef, gp120 and Tat. 
HIV Nef increases ERK1/2 activity in primary CD4 T lymphocytes through the recruitment 
of Lck and PKCθ to lipid rafts, potentially enhancing HIV transcription (Schrager et al., 
2002; Witte et al., 2008). Popik et al. have shown that activation of Raf-1 and the MAP 
kinase pathway by binding of HIV-1 envelope glycoproteins to CD4 receptors leads to 
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the transcriptional activation of expression of the early inflammatory genes (Popik et al., 
1998). Lastly, Tat, a viral immunosuppression factor, upregulates programmed death-
ligand 1 (PDL-1, also known as B7-H1) in an ERK1/2-dependent manner, leading to 
expression of the anti-inflammatory cytokine IL10, which may contribute to disease 
progression (Planès et al., 2014; Shi et al., 2011; Trabattoni et al., 2003). 
Several members across the large family of herpesviruses have also been described to 
modulate the ERK1/2 signalling cascade (Table 1). ERK1/2 modulation in host cells has 
been described for alpha-, beta- and gamma-herpesviruses, although the responsible 
viral factors, the underlying molecular mechanism and/or biological consequences are 
often poorly understood. Moreover, how the virus manipulates the ERK1/2 signalling 
pathway and the way how subsequent effects manifest often seems to depend on the 
cell type. 
Within the Alphaherpesvirinae subfamily, HSV-1 has been reported to either induce or 
inhibit ERK1/2 activity, once again apparently dependent on the cell type. In epithelial 
cells, HSV-1 leads to ERK1/2 activation in the early stages of infection, which seems to 
contribute to viral replication (Torres et al., 2012). HSV-1 also induced ERK1/2 in B cells 
(lymphoma cell line), and this activation is partially responsible for HSV-1-induced 
Kaposi-Sarcoma herpesvirus (KSHV) replication (Qin et al., 2013). More recently it has 
also been shown that HSV-1-mediated ERK1/2 activation in neuronal cells 
(neuroblastoma cell line) controls virus-induced filopodia formation and possibly 
contributes to viral entry (Zheng et al., 2014). Whilst these studies demonstrated ERK1/2 
activation caused by the virus, others reported that HSV-1 suppresses ERK1/2 activity in 
fibroblasts, an effect mediated by the viral US3 protein kinase (Chuluunbaatar et al., 
2012)..Although the precise consequences of this ERK1/2 suppression were not 
investigated, the authors hypothesized that it may take part in US3-associated functions 
during HSV-1 infection, like its anti-apoptotic effect and/or effect on gene expression 
(Chuluunbaatar et al., 2012).
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Table 1 - Herpesviruses interaction with the ERK1/2 signalling cascade 
Virus Cell type 
Viral factors/ 
mechanism of action 
Consequences of ERK1/2 viral manipulation References 
HSV-1 
Epithelial cells NS Effective viral replication Torres et al., 2012 
B cells NS HSV-1-induced KSHV replication Qin et al., 2013 
Neuronal cells NS 
Virus-induced filopodia formation and contribution to viral 
entry 
Zheng et al., 2014 
Fibroblasts US3 inhibits ERK1/2 activation NS Chuluunbaatar et al., 2012 
HSV-2 
Vero cells ICP10 activates ERK1/2 
Timely onset of virus growth expression of viral immediate-
early proteins 
Smith et al., 2000 
Neuronal cells ICP10 activates ERK1/2 Inhibition of caspase 3-mediated apoptosis 
Perkins et al., 2002;  
Perkins et al., 2003 
HEK 293 cells 
Virus activates ERK1/2 in a 
sustained manner 
Effective viral replication Zhang et al., 2010 
VZV Epithelial cells ORF12 activates ERK1/2 
Effective viral replication 
Degradation of pro-apoptotic proteins Bim and Bad 
Liu and Cohen, 2014;  
Liu et al., 2012 
PRV 
Epithelial cells 
UL46 (VP11/12) activates 
ERK1/2 
NS Schulz et al., 2014 
Fibroblasts 
US2 binds and sequesters 
ERK1/2 
Prevention of ERK1/2 nuclear translocation 
Kang and Banfield, 2010; 
Lyman et al., 2006 
Plasmacytoid DCs 
gE supresses ERK1/2 
phosphorylation 
Suppression of TI-IFN production Lamote et al., 2017 
BHV-1 MDBK cells Bi-phasic ERK1/2 activation NS Zhu et al., 2011 
MDV Fibroblasts Meq activates ERK1/2 Cell proliferation Subramaniam et al., 2013 
HCMV 
Fibroblasts 
Early and sustained ERK1/2 
activation 
Activation of transcription factors that control early viral 
gene expression and DNA replication 
Chen and Stinski, 2002; 
Rodems and Spector, 1998 
Endothelial cells NS 
Pro-survival signalling and protection of the cell against free 
radical-induced apoptosis 
Wang et al., 2006 
Myeloid cells 
gB activates ERK1/2 upon virus 
binding and entry 
Activation of ERK1/2 triggers the upregulation of key cell 
survival protein Mcl-1 
Reeves et al., 2012 
Dendritic cells 
Interleukin 6 signals through the 
ERK1/2 
Reactivation of IE gene expression Reeves and Compton, 2011 
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Virus Cell type 
Viral factors/ 
mechanism of action 
Consequences of ERK1/2 viral manipulation References 
EBV 
Epithelial cells Rta activates ERK1/2 Maintenance of the lytic state and induction of autophagy 
Hung et al., 2014;  
Lee et al., 2008 
Epithelial cells 
B lymphocytes 
LMP2A activates ERK1/2 Modulation of Bim and protection against cell death 
Clybouw et al., 2005;  
Iwakiri et al., 2013 
Epithelial cells LMP1 activates ERK1/2 Promotion of malignant transformation 
Meckes et al., 2013;  
Roberts and Cooper, 1998 
Burkitt’s lymphoma 
cell line and epithelial 
cells 
Virus activates ERK1/2 in a 
transient manner 
Contribution to cell-cell transmission from infected 
lymphoma cells to EBV-negative epithelial cells 
Nanbo et al., 2012 
KSHV 
B cell lymphoma 
Bi-phasic ERK1/2 activation, first 
upon virus binding entry and 
later during gene expression 
Essential for establishment of lytic infection 
Kuang et al., 2008;  
Naranatt et al., 2003; 
Ford et al., 2006 
Fibroblasts 
Endothelial cells 
gpK8.1A and gB activate ERK1/2 
upon virus binding to the cell 
Essential for to viral gene expression and establishment of 
infection 
Sharma-Walia et al., 2005 
Endothelial cells 
Virus inhibits cellular ERK1/2 
phosphatases 
Latent viral gene expression, induction of promigratory 
factors, and cell invasiveness 
Qin et al., 2013 
B lymphocytes 
ORF45 mediates activation of 
RSK by ERK1/2 
Accumulation of transcription factors that control the virus 
lytic life cycle 
Fu et al., 2015; Kuang et al., 
2008; Kuang et al., 2009; Li et 
al., 2015 
NS= Not specified 
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Studies on HSV-2 have shown that the viral ICP10 protein kinase (ICP10 PK), which is 
unique for HSV-2, activates ERK1/2 in non-neuronal (Vero cells) and neuronal 
(hippocampal primary cultures) cells (Perkins et al., 2002; Perkins et al., 2003; Smith et 
al., 2000). In Vero cells, activation of the ERK1/2 signalling pathway by ICP10 PK is 
essential for a timely onset of HSV-2 growth. This activation may also play an important 
role in the expression of viral IE proteins (Smith et al., 2000). In neuronal cells, ICP10 PK 
activates ERK1/2 leading to the inhibition of caspase 3-mediated apoptotic cell death 
(Perkins et al., 2002; Perkins et al., 2003). In human embryonic kidney cells (HEK 293), 
HSV-2 infection was shown to activate ERK1/2 in a sustained manner and inhibition of 
ERK1/2 signalling severely impaired viral growth, a process that is mainly dependent on 
MEK1 rather than MEK2 (Zhang et al., 2010). Similarly, ERK1/2 signalling induced by VZV 
ORF12 was required for effective virus replication during infection of epithelial cells (Liu 
et al., 2012). In addition, ERK1/2 activation in VZV-infected epithelial cells is associated 
with degradation of the pro-apoptotic proteins Bim and Bad, therefore contributing to 
cell survival during infection (Liu and Cohen, 2014; Liu et al., 2012).  
For PRV, viral infection has been reported to activate ERK1/2 and three viral proteins 
have been described to tamper with the ERK1/2 signalling pathway. In PRV-infected 
fibroblasts, the US2 protein, although not affecting the activation of ERK1/2 per se, has 
been shown to bind and sequester ERK1/2, targeting it to the plasma membrane. 
Furthermore, binding of US2 to ERK1/2 did not prevent activation of the latter, which 
suggests that US2 may serve as a spatial regulator of ERK1/2. The authors argued that 
the interaction of US2 with ERK1/2 results in preventing this kinase from being 
translocated to the nucleus, where it may activate undesirable transcription factors, and 
also that the virus may use this interaction to recruit ERK1/2 where it is needed during 
virus replication (Kang and Banfield, 2010; Lyman et al., 2006). The interaction between 
US2 and ERK1/2 was not observed during HSV-2 infection, suggesting that the two 
homologues (PRV US2 and HSV-2 US2) may interact with a different subset of proteins 
(Kang et al., 2013). Another PRV protein, UL46 (or VP11/12), was reported to activate 
ERK1/2 in epithelial cells (Schulz et al., 2014). Contrary to what was observed in infected 
fibroblasts, active ERK1/2 was able to reach the nucleus, where it activated Elk-1, a well-
known ERK1/2 substrate. The function of UL46-mediated ERK1/2 activation remains 
elusive (Schulz et al., 2014). Additionally, and very recently, it has been demonstrated 
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that the absence of the glycoprotein gE leads to ERK1/2 phosphorylation in plasmacytoid 
dendritic cells (pDC), which correlates with an increase in TI-IFN production (Lamote et 
al., 2017). 
Other alphaherpesviruses were also found to modulate the ERK1/2 signalling pathway, 
like BHV-1 and Marek’s disease virus. BHV-1 induces ERK1/2 activation in a bi-phasic 
manner, although the biological relevance for viral replication was not clear (Zhu et al., 
2011). In Marek’s disease, Meq, a viral protein critically involved in viral-induced 
tumorigenesis, activates ERK1/2 signalling pathway, consequently inducing cell 
proliferation. Meq is also responsible for the downregulation of certain phosphatases, 
which are known to deactivate MAPK (Subramaniam et al., 2013).  
Betaherpesvirinae appear to equally depend on and/or modulate the ERK1/2 signalling 
cascade. Human cytomegalovirus (HCMV) triggers an early and sustained ERK1/2 
activation in infected human fibroblasts (up to 8 hours post inoculation), and this 
activation contributes to the activation of transcription factors that control early viral 
gene expression and DNA replication (Chen and Stinski, 2002; Rodems and Spector, 
1998). HCMV infection also activates ERK1/2 in endothelial cells, contributing to pro-
survival signalling and protecting the cell against free radical-induced apoptosis (Wang 
et al., 2006). Moreover, HCMV activates ERK1/2 in myeloid cells upon virus binding and 
entry, upregulating the key cell survival protein myeloid cell leukaemia 1 (Mcl-1). This 
activation of the ERK1/2 signalling pathway is mediated by the viral envelope protein gB 
(Reeves et al., 2012). ERK1/2 has also been shown to be one of the key players in 
reactivation of HCMV after dendritic cell differentiation (Reeves and Compton, 2011).  
For the Gammaherpesvirinae, Epstein-Barr virus (EBV) and the Kaposi’s sarcoma 
associated-herpesvirus (KSHV) have been shown to activate ERK1/2. Three viral proteins 
belonging to EBV have been reported to be involved in activation of ERK1/2 and each 
one is linked to different cellular/viral events. ERK1/2 activation by the IE protein Rta 
was shown to be essential for maintenance of the lytic state and induction of autophagy 
in EBV-infected epithelial cells (Hung et al., 2014; Lee et al., 2008). Phosphorylation of 
ERK1/2 in EBV-infected cells mediated by another viral protein, the latent membrane 
protein 2A (LMP2A), has been shown to correlate with modulation of Bim and protection 
against cell death in both epithelial cells and B lymphocytes (Clybouw et al., 2005; Iwakiri 
et al., 2013). Finally, the latent membrane protein 1 (LMP1) activates ERK1/2 signalling 
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to promote malignant transformation of epithelial cells (Meckes et al., 2013; Roberts 
and Cooper, 1998). The ERK1/2 pathway also plays a role in the trafficking of virions to 
the intercellular space, contributing to cell-cell transmission from infected lymphoma 
cells to EBV-negative epithelial cells (Nanbo et al., 2012). 
In KSHV-infected fibroblasts, the ERK1/2 signalling pathway was found to be essential 
during primary infection. In these cells, ERK1/2 is activated in a biphasic manner, firstly 
after virus binding and entry and later during gene expression (Kuang et al., 2008; 
Naranatt et al., 2003). ERK1/2 activation has also been described as a trigger for 
reactivation of the virus in B lymphocytes (Ford et al., 2006). Also, de novo infection of 
KHSV suppresses ERK1/2 phosphatases in endothelial cells, leading to an effective ERK-
dependent latent viral gene expression, induction of promigratory factors, and cell 
invasiveness (Qin et al., 2013). Two proteins have been implied in the KSHV-mediated 
ERK1/2 activation that contributes to viral gene expression: gpK8.1A and gB (Sharma-
Walia et al., 2005). Furthermore, a third KSHV protein, ORF45, mediates activation of 
RSK by ERK1/2, leading to accumulation of transcription factors that will take part in the 
control of the KHSV lytic life cycle in B lymphocytes (Fu et al., 2015; Kuang et al., 2008; 
Kuang et al., 2009; Li et al., 2015).  
The overview above describes that herpesviruses interfere with the ERK1/2 signalling 
pathway throughout different stages of the virus replication cycle and the consequences 
of this manipulation are diverse. Herpesviruses seem to have evolved to take full 
advantage of this pleitropic signalling pathway, re-directing ERK1/2 function to 
contribute to the regulation of gene expression, effective viral replication, protection 
against apoptosis, cell proliferation, virus reactivation from latency and cell-cell spread. 
For several viruses, viral proteins have been described to mediate virus-induced ERK1/2 
signalling (including glycoproteins, like gB), however information regarding the 
molecular details how these viruses trigger ERK1/2 signalling (e.g corresponding cellular 
ligands) is often lacking. To this date, investigation of PRV interference with the ERK1/2 
signalling in different cellular contexts and potential biological outcomes have been 
fairly limited. As presented earlier in this chapter, the glycoprotein E (gE) has been 
suggested to be involved in cellular signalling events, however no concrete link to a 
specific signalling pathway has been demonstrated so far. Considering this, we 
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questioned whether PRV effect on ERK1/2 signalling pathway could be further 
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Herpesviruses are outstanding manipulators of the host cell machinery, ensuring 
successful viral replication and spread, as well as achieving life-long persistence in their 
hosts. Over the years, our group has been studying the role of different pseudorabies 
virus (PRV) viral proteins in different aspects of virus-host interaction, including virus 
interference, either direct or indirect, with different cellular signalling pathways. One of 
these proteins, the glycoprotein E (gE), was reported to display potential signalling 
capabilities, such as species-specific Fcγ receptor-like activity (Favoreel et al., 1997; 
Johnson et al., 1988; Litwin et al., 1992) as well as driving signalling-dependent processes 
like cell surface antigen capping (Desplanques et al., 2007; Favoreel et al., 1997; Rizvi 
and Raghavan, 2003). Despite these earlier studies, there are no reports connecting gE 
with a particular signalling pathway.  
The central ERK1/2 signalling pathway has been widely studied in the context of viral 
manipulation of the host, as it controls a large variety of cellular events (Chong et al., 
2003; O’Neill and Kolch, 2004; Seger and Krebs, 1995; Torii et al., 2004; Viala and 
Pouysségur, 2004; Wellbrock et al., 2004; Yoon and Seger, 2006). Many herpesviruses 
have been reported to interfere with the ERK1/2 signalling pathway, including PRV, 
which has been shown to activate ERK1/2 in infected epithelial cells and fibroblasts 
(Lyman et al., 2006; Kang and Banfield, 2010; Schulz et al., 2014). 
In the present thesis, the main aim was to investigate the potential ability of gE to 
interfere with the host signalling machinery and consequent biological effects that may 
contribute to viral replication and spread. Specifically, we focused on exploring a 
potential connection between gE and the modulation of the ERK1/2 signalling pathway 
during PRV infection.  
Immune evasion is one of the key elements to the success of herpesvirus infections. The 
ERK1/2 signalling cascade can control several aspects of T cell activity. Since little has 
been reported about the interaction between PRV and T lymphocytes, the first objective 
of this thesis was therefore to explore the effect of PRV infection on ERK1/2 activation 
in the Jurkat T cell line, as well as the role of gE in this process (Chapter 3a). Going 
forward, we investigated whether PRV gE modulates ERK1/2 activation in primary 
porcine T lymphocytes, and potential changes in cellular behaviour due to the activation 
of this signalling pathway mediated by gE (Chapter 3b). Together with the objectives 
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mentioned above, we also aimed at unravelling part of the mechanism used by gE to 
modulate this central signalling pathway (Chapters 3.1 and 3.2).  
ERK1/2 is not only involved in T cell activity, but also in promoting cell survival. PRV has 
been described to suppress apoptosis of infected cell, although thus far, only one anti-
apoptotic PRV protein has been described (US3). Therefore, in the last experimental 
chapter of this thesis (Chapter 4), we aimed at understanding whether PRV- and/or gE-
mediated ERK1/2 signalling modulation can also be observed in epithelial cells and 
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ABSTRACT 
The interaction between viruses and immune cells of the host may lead to modulation 
of intracellular signalling pathways, and subsequent changes in cellular behavior that 
may have important consequences for both virus and host. The ERK1/2 (Extracellular 
signal Regulated-Kinase 1/2) signalling pathway is a key cellular signalling axis that 
controls many fundamental cellular processes. In this chapter we show that the porcine 
alphaherpesvirus pseudorabies virus (PRV) activates the ERK1/2 signalling pathway in 
infected Jurkat T cells. Furthermore, experiments using virus mutants and recombinant 
proteins show that the glycoprotein E (gE) of PRV plays a key role in PRV-triggered 
ERK1/2 activation. In summary, we show that PRV induces ERK1/2 activation in Jurkat T-























Alphaherpesviruses are the largest subfamily of the Herpesviruses. This subfamily 
contains closely related pathogens, including herpes simplex virus 1 and 2 (HSV-1 and 
HSV-2) and varicella zoster virus (VZV) in man. Another member of the alphaherpesvirus 
subfamily is the porcine pseudorabies virus (PRV) that is often used as a model to study 
general features of alphaherpesvirus biology  (Pomeranz et al., 2005).  
PRV encodes 11 envelope glycoproteins (Mettenleiter, 2000) that are incorporated in 
different host membranes of the infected cell, including the plasma membrane. One of 
these glycoproteins is the glycoprotein E (gE), which is important for virulence and viral 
(neuronal) spread (Babic et al., 1996; Banfield et al., 1998; Enquist et al., 1994; 
Kratchmarov et al., 2013; Kritas et al., 1994; Lomniczi et al., 1984; Mettenleiter et al., 
1985; Mettenleiter et al., 1987). For both PRV and HSV-1 there are indications that gE 
may have a signalling function in immune cells, as it drives signalling-dependent 
processes like cell surface antigen capping (Desplanques et al., 2007; Favoreel et al., 
1997; Rizvi and Raghavan, 2003). However, to date, there are no reports that gE indeed 
triggers any particular signalling pathway.  
The ERK1/2 MAPK signalling pathway (ERK for extracellular signal-regulated kinase and 
MAPK for mitogen-activated protein kinase) is an evolutionary conserved pathway, 
controlling many fundamental cellular events (Chong et al., 2003; O’Neill and Kolch, 
2004; Wellbrock et al., 2004). It may come as no surprise that many viruses, including 
alphaherpesviruses, modulate the ERK1/2 signalling pathway (Chuluunbaatar et al., 
2012; Kang and Banfield, 2010; Liu et al., 2012; Lyman et al., 2006; Schulz et al., 2014).  
Several studies have described alphaherpesvirus modulation of ERK1/2 signalling in 
fibroblasts and/or epithelial cells, but relatively little is known about such modulation in 
immune cells. PRV has been reported to interact with T lymphocytes (Page et al., 1992; 
Wang et al., 1988a). ERK1/2 is involved in key aspects of T cell activation, therefore 
investigating the modulation of this signalling pathway may provide valuable insights to 
understand certain aspects of immune evasion and the pathogenesis of the virus (Aubert 
et al., 2009; Naci and Aoudjit, 2014; Sen et al., 2014; Sloan and Jerome, 2007; Sloan et 
al., 2006; Zerboni et al., 2014a). In this chapter we describe that PRV activates ERK1/2 
signalling in the Jurkat T cell line and that PRV gE plays an important role in this process. 
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These data provide additional insights in the interaction of PRV with T lymphocytes and 
reveal a new role for gE during PRV infection, which may contribute to our 
understanding of the complex interaction that alphaherpesviruses like PRV have 
developed with the host immune system.  
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MATERIALS AND METHODS 
Cells and viruses 
The Jurkat T cell line was derived from a patient with acute T-cell leukemia (Gillis and 
Watson, 1980) and analysis of cell surface markers revealed that these cells express CD7 
(pan-T-cell-specific marker, widely expressed from pro-T-cell to mature T-cell), CD2 and 
CD5 (expressed from early thymocyte to mature thymocyte), and CD3 and CD4 (mature 
T-cell marker) (Inoue et al., 2014). The cells, clone E6-1, were purchased from the 
American Type Culture Collection (www.atcc.com) and grown in RPMI 1640 (Life 
Technologies, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (Life 
Technologies), 100 U/mL penicillin and 0.1 mg/mL streptomycin (Life Technologies). PRV 
wild type (WT, Becker strain) and isogenic mutants, gEnull PRV 91 (PRV ΔgE, (Tirabassi 
et al., 1997)) and PRV107, lacking the cytoplasmic domain of gE (gEΔcd, (Tirabassi and 
Enquist, 1999)), were grown and titrated on ST cells, and stored at −80°C. PRV Becker 
and its isogenic mutant viruses were a kind gift from L. Enquist, Princeton University.  
 
Infection and T cell stimulation 
Jurkat T cell infection was performed in 24-well plates. Cells (1.5x106) were inoculated 
with either PRV WT or the isogenic mutants PRVΔgE and PRV gEΔcd at a multiplicity of 
infection (MOI) of 10 for 24 hours (except when mentioned otherwise). For TCR 
stimulation, mock- or PRV-infected cells were incubated with anti-CD3 antibody (OKT3, 
10 µg/ml) for 30 min on ice and subsequently incubated with a secondary antibody (goat 
anti-mouse IgG) again on ice for 30 min. The cells were then placed at 37 °C for 5 min, 
and lysed immediately. For T cell stimulation assays using gE recombinant protein, Jurkat 
T cells (1x106/ml) were resuspended in medium containing 10 µg/ml of gE recombinant 
protein (Gut et al., 1999) and incubated for different time points at 37°C. To block gE-
triggered stimulation, gE recombinant protein was incubated prior to stimulation with 
two different antibodies raised against gE, a rabbit polyclonal (1/100) and a mouse 
monoclonal (1/100) antibody, for 30 min at 37 °C. Both gE recombinant protein and 
polyclonal antibody against gE were a kind gift of K. Bienkowska-Szewczyk, University of 
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After infection or gE stimulation, cells were washed with PBS, resuspended in ice-cold 
lysis buffer (TNE buffer, 10% NP40, 1 mM Na3VO4, 10 mM NaF, protease inhibitor 
cocktail) and incubated for 20 min at 4 °C. SDS-PAGE and Western blotting were 
performed as described previously (Deruelle et al., 2007). Protein concentrations of 20 
to 30 μg were used for all experiments. Protein concentration was determined using the 
bicinchoninic acid (BCA) protein assay reagent (Thermo Scientific) according to the 
manufacturer's instructions. Blots were blocked in 5% nonfat dry milk in phosphate-
buffered saline (PBS)–Tween 20 for 1 h at room temperature and incubated with primary 
antibodies for 1 h or overnight (according to the manufacturer's instructions). After 
several washes in 0.1% Tris-buffered saline (TBS)–Tween 20 (TBS-T), blots were 
incubated with HRP-conjugated secondary antibodies for 1 h at room temperature and 
developed using enhanced chemiluminescence. Phospho-specific ERK1/2 antibody 
(1/1000; Cell Signalling) signal was detected with ECL Plus (GE Healthcare). Total ERK1/2 
antibody (1/1000; Cell Signalling) signal and viral protein antibody – gE (1/500), US3 
(1/500) and gB (1/200) – signals used as loading and infection controls, respectively, 
were detected with Pierce ECL (Thermo Scientific). 




PRV modulates ERK1/2 activation in Jurkat T cells 
We first analysed whether PRV affects ERK1/2 signalling in T cells. To this end, Jurkat T 
cells were used, a cell line widely utilized for signalling and functional studies in T cells 
(Abraham and Weiss, 2004). Cells were either mock-inoculated or inoculated with PRV 
wild type (WT) and ERK1/2 phosphorylation was assessed by Western Blot. Figure 1A 
indicates that at 24 hours post-inoculation (hpi), levels of ERK1/2 phosphorylation were 
substantially increased in infected Jurkat T cells when compared to mock-infected cells. 
A time course assay showed that PRV induces ERK1/2 phosphorylation at a relatively 
late stage of infection, from 12 hpi onwards (Figure 1B), suggesting the potential 
involvement of late/structural viral proteins. Onset of ERK1/2 phosphorylation coincided 
with expression of the viral gE protein (Figure 1B). A common method of triggering 
ERK1/2 signalling in T lymphocytes occurs via the T cell receptor (TCR) (Sloan and 
Jerome, 2007; Sloan et al., 2006; Walker et al., 1987) and antibody-induced crosslinking 
of the CD3 T cell co-receptor complex typically results in robust ERK1/2 signalling (Koike 
et al., 2003; Poltorak et al., 2013). To investigate whether CD3-mediated ERK1/2 
activation is affected in PRV-infected cells, CD3 was crosslinked on mock- or PRV-
infected Jurkat T cells (at 24 hpi) and ERK1/2 activation was assessed. Interestingly, in 
contrast to mock-infected cells, stimulating PRV-inoculated Jurkat T cells with an anti-
CD3 antibody did not trigger ERK1/2 activation (Figure 1C). These data indicate that PRV 
triggers ERK1/2 activation during infection of Jurkat T cells and at the same time 





















Figure 1. PRV infection induces ERK1/2 phosphorylation in Jurkat T cells. (A) Cells were either mock-
inoculated or inoculated with PRV WT (MOI 10) and lysed at 24 hpi. ERK1/2 activation was detected via 
Western Blot using a phospho ERK1/2-specific antibody. Loading and infection controls were performed 
by detecting for total ERK1/2 and viral proteins gB and US3, respectively. (B) A time course of infection 
was performed, where cells were either mock-inoculated or inoculated with PRV WT (MOI 10) and lysed 
at different time points post inoculation. Phospho and total ERK1/2 and viral protein gE were detected. 
(C) At 24 hpi, mock- or PRV-infected cells were left untreated or stimulated with an anti-CD3 antibody for 
5 min to induce TCR-dependent ERK1/2 activation.  m: mock. 
 
Glycoprotein E is required for PRV-induced ERK1/2 activation in 
Jurkat T cells 
Alphaherpesvirus gE is involved in viral cell-cell spread (Babic et al., 1996; Banfield et al., 
1998; Johnson et al., 2001b) as well as other functions. It has been suggested that gE of 
different alphaherpesviruses may affect cell signalling, although gE-mediated 
modulation of a particular signalling axis has not been demonstrated before 
(Desplanques et al., 2007; Favoreel et al., 1997; Favoreel et al., 1999; Favoreel et al., 
2004; Olson et al., 1997; Riteau et al., 2006; Rizvi and Raghavan, 2003). To investigate if 
gE is involved in PRV-induced ERK1/2 activation, Jurkat T cells were inoculated with 
either PRV WT or an isogenic PRV mutant that lacks gE expression (PRVΔgE). ERK1/2 
phosphorylation was assessed at 24 hpi (Figure 2A). Contrary to PRV WT, infection with 
PRVΔgE did not cause ERK1/2 phosphorylation, indicating that gE is required for PRV-
mediated ERK1/2 activation. The cytoplasmic domain of PRV gE contains potential 
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signalling domains, i.e. tyrosine-based YXXΦ motifs (Desplanques et al., 2007). We used 
another isogenic PRV mutant, lacking the cytoplasmic domain of gE (PRV gEΔcd), to 
study the involvement of putative cytoplasmic signalling domains in ERK1/2 activation 
(Figure 2B). Jurkat T cells were inoculated with PRV WT, PRVΔgE or PRV gEΔcd, and 
ERK1/2 phosphorylation was detected at 24 hpi. The absence of the cytoplasmic domain 
of gE did not affect PRV-mediated ERK1/2 activation, as ERK1/2 phosphorylation levels 
were similar when cells were infected with either PRV gEΔcd or PRV WT. These results 
show that ERK1/2 activation upon PRV infection depends on gE, but does not require 










Figure 2. The gE glycoprotein is required for PRV-induced ERK1/2 phosphorylation in Jurkat T cells. (A-B) 
Cells were mock-inoculated or inoculated with PRV WT (A, B), PRV ΔgE (A) or PRVgEΔcd (B) (MOI 10) and 
lysed at 24 hpi. ERK1/2 activation was detected via Western Blot using a phospho ERK1/2-specific Ab. 
Loading and infection controls were performed by detecting for total ERK1/2 and US3, respectively. 
Glycoprotein gE was also detected to confirm absence of the entire protein or the cytoplasmic domain. 
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Addition of recombinant gE to Jurkat T cells leads to rapid and 
transient ERK1/2 activation 
To further confirm that gE affects ERK1/2 phosphorylation through its extracellular 
domain, Jurkat T cells were incubated with recombinant gE protein for several time 
points. Already at 2 minutes post incubation there was a clear increase in ERK1/2 
phosphorylation (Figure 3A) that quickly decreased, reaching background levels at 5 
minutes post incubation. Pre-incubation of recombinant gE with gE-specific antibodies 
prior to Jurkat T cells stimulation abrogated its ability to induce ERK1/2 phosphorylation, 
confirming that the effect is gE-dependent (Figure 3B). Thus, binding of PRV gE to Jurkat 








Figure 3. Addition of gE recombinant to Jurkat T cells results in rapid and transient ERK1/2 
phosphorylation. (A) Cells were stimulated for different time points with recombinant gE (10 µg/ml), lysed 
and ERK1/2 phosphorylation was detected. (B) Recombinant gE was pre-incubated for 30 min with two 
blocking antibodies (mAb and pAb, 1/100) raised against gE, prior to stimulation of Jurkat T cells for 2 min 












Interaction between alphaherpesviruses and ERK1/2 signalling has been studied 
extensively over the past years (Chuluunbaatar et al., 2012; Kang and Banfield, 2010; Liu 
et al., 2012; Lyman et al., 2006; Schulz et al., 2014; Sloan and Jerome, 2007). This 
signalling axis controls various fundamental cellular events, making it an attractive 
target for the virus to subvert the host, as it has the potential to promote viral replication 
and survival of infected cells.  
The current data show that PRV activates the ERK1/2 signalling pathway in infected 
Jurkat T cells. In addition, the virus appears to actively regulate this signalling cascade, 
since at the same time PRV interfered with ERK1/2 activation via classical T cell 
stimulation through CD3. Regulation or modulation of the ERK1/2 signalling pathway in 
T cells has been reported before for alphaherpesviruses. Similarly to what we observed 
for PRV, HSV-1 seems to “hijack” the signalling cascade, inhibiting T cell receptor (TCR)-
induced ERK1/2 activation (Sloan and Jerome, 2007; Sloan et al., 2006). The T cell-tropic 
VZV modulates TCR-dependent signalling by triggering the depletion of CD3 (Sen et al., 
2014).  
PRV-induced ERK1/2 activation occurred during later stages of virus infection, 
suggesting the involvement of late/structural viral proteins. This was confirmed by our 
finding that ERK1/2 phosphorylation is triggered by the glycoprotein E (gE). Moreover, 
infection with the virus mutant PRV gEΔcd and incubation with a gE recombinant protein 
provided evidence that ERK1/2 activation is mediated by the extracellular domain of gE. 
One possible interpretation of these results is that gE may bind to an unidentified 
cellular receptor on the surface of T lymphocytes, thereby triggering ERK1/2 activation. 
This way of ERK1/2 activation has been reported before for HIV-1, where extracellular 
binding of gp120 recombinant protein to its receptor CXCR4 transiently activates ERK1/2 
in T cells (Popik et al., 1998). A cellular interaction partner for the extracellular domain 
of gE has only been reported for VZV (insulin-degrading enzyme), but not for any of the 
other alphaherpesviruses, including PRV (Li et al., 2006).  
We noticed that addition of recombinant gE triggered transient ERK1/2 activation, 
whereas gE-dependent ERK1/2 signalling during productive infection of Jurkat T cells 
appeared to be continuous for several hours. We propose that differences in transient 
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versus continuous ERK1/2 activation can possibly be explained by dynamic cell-cell 
interactions and gE availability. T cell interactions, either homotypic or with antigen 
presenting cells, can be transient, allowing the T cells to establish contact with different 
cells during a given time period (Hugues et al., 2004; Sabatos et al., 2008). In infected 
cells, there is an ongoing expression of gE on the plasma membrane, and dynamic 
interactions between cells may cause gE to bind (and detach) repeatedly to its possible 
receptor, resulting in almost continuous repetitive, rather than truly sustained, ERK1/2 
activation. On the other hand, binding of recombinant gE led to a rapid but transient 
activation, possibly due to the non-dynamic nature of the interaction. Although 
speculative, upon binding, gE recombinant may remain attached, preventing binding of 
soluble gE still present in the medium.  
It would be interesting to study if the novel function of gE reported here for PRV is 
conserved in other alphaherpesviruses. In HSV-infected Jurkat T cells, there are 
indications that gE may take part in the inhibition of TCR-dependent cell activation 
(measured by calcium flux). However, a direct correlation between gE and ERK1/2 
activity was not assessed (Aubert et al., 2009; Sloan and Jerome, 2007; Sloan et al., 
2006). During PRV infection, we could observe virus-induced modulation of TCR-
mediated ERK1/2 activation, although gE appeared not to be involved in this event (data 
not shown). Future research may clarify whether the observed differences are virus-
dependent or reflect differences in experimental setup. In any case, previous data on 
PRV and HSV together with our current data provide strong evidence for an involvement 
of alphaherpesvirus gE with the cell signalling machinery. Further studies would help to 
elucidate if these signalling features of gE can be observed in primary T lymphocytes or 
other cell types. Together, our results shed light on a potential new function for gE 














Chapter 3b: P R V  gE t r igge r s  ER K1 /2 -de pe nde nt  ce l l  aggr e gat ion  and m igr at ion  of  por c ine  pr im ar y  lym phot e s 
 
PRV gE TRIGGERS ERK1/2-DEPENDENT CELL 
AGGREGATION AND MIGRATION OF PORCINE 













Herpesviruses are known to be highly successful in evading the immune system of their 
hosts, subverting cellular signalling cascades to their own advantage. The ERK1/2 
signalling pathway, being involved in many cellular processes, represents a particularly 
attractive target for viral manipulation. Pseudorabies virus, a member of the 
Alphaherpesvirinae subfamily, has been reported previously to interfere with this 
signalling pathway in different cell types. We have shown in the previous chapter that 
PRV activates ERK1/2 in infected Jurkat T cells and that this is mediated by the 
extracellular domain of the glycoprotein E (gE). Here, we report that gE triggers ERK1/2 
phosphorylation in porcine primary T lymphocytes, leading to cellular aggregation and 
increased migration of these cells, two hallmarks of T cell activation. This study further 
unravels the contribution of gE in the crosstalk between PRV and T lymphocytes, and 





















Members of the large Herpesviridae family have been highly successful in manipulating 
the immune system, i.e. by perturbing recognition of virus infected cells by virus-specific 
T cells and consequent T cell activation (Adhikary et al., 2006; Wiertz et al., 2007; Zerboni 
et al., 2014b). In addition, some of these viruses have acquired the ability to use immune 
cells as a vehicle for viral dissemination, which may contribute importantly to viral 
pathogenesis (Arvin et al., 2010; Gryspeerdt et al., 2010; Laval et al., 2015; Nauwynck 
and Pensaert, 1992; Nauwynck and Pensaert, 1995b; Smith et al., 2004). The interaction 
between herpesviruses and immune cells of the host may lead to modulation of specific 
intracellular signalling pathways, and subsequent changes in cellular behavior that may 
be of benefit for the virus.  
The ERK1/2 signalling cascade controls many fundamental cellular events, representing 
a very attractive target for viruses (Chong et al., 2003; Hindley and Kolch, 2002; Naci and 
Aoudjit, 2014; O’Neill and Kolch, 2004; Wellbrock et al., 2004). Investigating ERK1/2 
modulation in T lymphocytes may be of particular interest as this signalling pathway is 
involved in T cell activation, aggregation and motility (Khunkaewla et al., 2008; Layseca-
Espinosa et al., 2003; Naci and Aoudjit, 2014; Sloan and Jerome, 2007) and since T 
lymphocytes may be involved in virus spread and transmission of some 
alphaherpesviruses. The latter is particularly evident for the Varicellovirus VZV, whose 
tropism for T cells contributes to several central aspects of its pathogenesis, including 
viral dissemination in the body, transmission to skin cells and spread to new hosts (Arvin 
et al., 2010; Sen et al., 2014; Zerboni et al., 2014b). Other members of the Varicellovirus 
genus like PRV have also been reported to interact with T lymphocytes (Page et al., 1992; 
Wang et al., 1988a).   
In the previous chapter, we have demonstrated that PRV activates the ERK1/2 signalling 
pathway in the Jurkat T cell line, a process mediated by the viral virulence factor 
glycoprotein E (gE). In the present chapter, we report that PRV gE-induced ERK1/2 
activation also occurs in primary porcine T lymphocytes and that, in vitro, this signalling 
leads to T lymphocyte aggregation and migration, and that migratory T lymphocytes may 
transfer the virus to susceptible host cells. These data provide additional insights in the 
interaction of PRV with T lymphocytes and reveal a new role for gE during PRV infection, 
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suggesting that PRV/gE-induced ERK1/2 activation may trigger PRV-carrying T 
lymphocytes to migrate and infect other cells that are susceptible to PRV replication.




MATERIALS AND METHODS 
Cells and viruses 
Porcine peripheral blood mononuclear cells (PBMC) were isolated from whole blood 
obtained from healthy pigs from 6 to 15 weeks using LymphoprepTM density 
centrifugation. Porcine primary CD6+ T lymphocytes were isolated as described before 
(Devriendt et al., 2013). Cells were enriched from PBMC to a purity of >95% by positive 
immunomagnetic selection with an α-CD6 mAb (IgG1, clone a38b2 (Saalmüller et al., 
1994)). A percentage of 39–76% of peripheral blood T cells express CD6. From this 
population the following subsets have been characterized: CD4+CD8+ double positive T 
lymphocytes, CD4+CD8− T helper cells and CD4−CD8high T cytolytic cells. CD4−CD8low and 
CD4−CD8− are majorly devoid of CD6, and a small percentage shows very low CD6 
density. CD6 is not expressed by B cells or by cells of the myeloid lineage (Pauly et al., 
1996; Piriou-Guzylack and Salmon, 2008).  CD6+ T lymphocytes were cultured overnight 
prior to stimulation in RPMI 1640 supplemented with 10% fetal bovine serum (FBS), 100 
U/mL penicillin, 0.1 mg/mL streptomycin and 0.2 mM HEPES (Life Technologies). Swine 
Testicle (ST) cells were grown in Eagle's minimal essential medium (MEM, Life 
Technologies) supplemented with 10% FBS, glutamine (0.3 mg/ml), and antibiotics (100 
U/ml penicillin, 0.1 mg/ml streptomycin). PRV wild type (WT, Becker strain) and isogenic 
mutant gEnull PRV 91 (PRV ΔgE, (Tirabassi et al., 1997)) were grown and titrated on ST 
cells, and stored at −80°C. PRV Becker and PRV91 (PRV ΔgE) were a kind gift of L. Enquist, 
Princeton University.  
 
Transfection and co-cultures 
ST cells were transfected according to the manufacturer’s guidelines (Jet Prime®, 
Polyplus Transfection™) with a plasmid encoding wild type gE (pIB2, kind gift of Lynn 
Enquist, (Tirabassi and Enquist, 1998)) for 48 hours. As a control, cells were transfected 
with either empty vector or a GFP-expressing plasmid (pcDNA-GFP, made in house). 
Rested T lymphocytes (2.5 x106 cells per well) were added to transfected ST cells and co-
cultured for different time periods. After co-culture, T lymphocytes were gently 
collected for analysis via SDS-PAGE and Western blot. To guarantee that the majority of 
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T lymphocytes would be collected, the wells were washed carefully with PBS, assuring 
that ST cells remained adherent.  
To determine transmission of infection from T cells to ST cells, primary porcine T 
lymphocytes were inoculated with PRV WT for 24 hours, treated with citrate buffer for 
1 min (40 mM Na citrate, 10 mM KCl, 135 mM NaCl, pH 3.0), washed 3 times with PBS-
1%FBS, and co-cultured with ST cells for another 24 hours. In some experiments, virus-
neutralizing anti-PRV polyclonal antibodies were added prior and during co-culture, 
neutralizing possibly remaining virus attached to the T lymphocyte cell surface. ST cells 




Cells were washed with PBS, resuspended in ice-cold lysis buffer (TNE buffer, 10% NP40, 
1mM Na3VO4, 10 mM NaF, protease inhibitor cocktail) and incubated for 20 min at 4 °C. 
SDS-PAGE and Western blotting were performed as described previously (Deruelle et 
al., 2007). Protein concentrations of 20 to 30 μg were used for all experiments. Protein 
concentration was determined using the bicinchoninic acid (BCA) protein assay reagent 
(Thermo Scientific) according to the manufacturer's instructions. Blots were blocked in 
5% nonfat dry milk in phosphate-buffered saline (PBS)–Tween 20 for 1 h at room 
temperature and incubated with primary antibodies for 1 h or overnight (according to 
the manufacturer's instructions). After several washes in 0.1% Tris-buffered saline 
(TBS)–Tween 20 (TBS-T), blots were incubated with HRP-conjugated secondary 
antibodies for 1 h at room temperature and developed using enhanced 
chemiluminescence. Phospho-specific ERK1/2 antibody (1/1000; Cell Signalling) signal 
was detected with ECL Plus (GE Healthcare). Total ERK1/2 antibody (1/1000; Cell 
Signalling) signal was detected with Pierce ECL (Thermo Scientific).  
 
Homotypic T cell aggregation assay 
Primary T lymphocytes (0.5x106) were placed in a 96-well plate and inoculated with 
either PRV WT or PRV ΔgE (MOI 100). When assessing the involvement of ERK1/2 
signalling, the ERK1/2 phosphorylation inhibitor U0126 (10 µM, Cell Signalling) was 




added to the T lymphocytes 30 minutes prior to inoculation with the virus and at 2 hours 
post inoculation (hpi). U0126 was dissolved in DMSO at 10 mM and diluted 1,000 x in 
medium to reach the working concentration. As a control, the same experiments were 
performed in the presence of the corresponding dilution of DMSO, and cell viability was 
tested for both the inhibitor and the solvent. At 24 hpi, 20 randomly selected fields per 
condition were observed under the microscope and pictures were taken. Cell aggregates 
were counted, and their surface area was measured using ImageJ 1.48. Background 
aggregation levels observed in mock-infected cells were used as threshold to distinguish 
small from large aggregates. This threshold was determined as the surface area at which 
≤2% of the identified aggregates in mock-infected samples had a larger surface area. For 
the other conditions, aggregates with a surface area above this threshold value were 
considered as large aggregates.  
 
Transwell® migration assay 
Primary T lymphocytes were inoculated with either PRV WT or PRV ΔgE (MOI 100). After 
24 hours of virus inoculation, primary T lymphocytes (0.5x106) were placed onto a 5 µm 
Corning® Transwell® (24-well plate, Sigma-Aldrich) and incubated further to allow 
migration. To determine levels of migration, a collagen-coated coverslip was placed at 
the bottom of each well, so that migrating cells would be able to attach to the coverslip. 
At 24 hours post incubation, Transwells were removed and the adherent cells were 
counted. When assessing the involvement of ERK1/2 signalling, U0126 was added to the 
T lymphocytes 30 minutes prior to virus inoculation and at 2 hpi. As a control, the same 
experiments were performed in the presence of DMSO-based U0126 diluent. 
 
Statistics 
Statistical analysis was performed on GraphPad Prism 5 (GraphPad Software, Inc). Data 
sets (n=3) were analysed using One-way ANOVA (p<0.05) combined with Tukey’s 
Multiple Comparison Test (95% confidence interval). 




Providing gE in trans leads to ERK1/2 activation in primary 
porcine T lymphocytes 
In the previous chapter we found that PRV gE activates ERK1/2 in the Jurkat T cell line, 
a widely used cell line for signalling and functional studies in T cells. To investigate 
whether PRV gE also leads to ERK1/2 activation in primary T cells of its natural host, in a 
first experimental assay, primary porcine T lymphocytes were incubated with 
recombinant gE for different time points (Figure 1A). Similar to our observations in 
Jurkat T cells, recombinant gE led to a fast increase in ERK1/2 phosphorylation, 
decreasing back to basal levels at 30 minutes. Since ERK1/2 activation appeared slightly 
less pronounced in primary porcine T lymphocytes compared to Jurkat T cells, a second 
experimental assay was used to confirm these findings. ST cells were transfected with a 
gE-expressing plasmid or, as control, empty vector or a GFP-expressing plasmid. At 48h 
post transfection, T lymphocytes were co-cultured with transfected ST cells for different 
time points. T lymphocytes incubated with gE-expressing ST cells showed an increased 
ERK1/2 activation already at 5 minutes post co-cultivation, followed by a slow decrease 
to almost basal levels at 30 minutes post co-incubation, which was not observed in T 
lymphocytes incubated with control plasmid-transfected ST cells (Figure 1B) or empty 
vector-transfected ST cells (data not shown). To ensure that the observed ERK1/2 
phosphorylation was not derived from co-cultured ST cells that might have detached 
from the bottom of the well during T lymphocyte collection, the same assay was 
performed without addition of T lymphocytes. Neither total ERK1/2 nor phosphorylated 
ERK1/2 could be detected (data not shown). Finally, in a third experimental assay, 
primary porcine T lymphocytes were brought into contact with PRV WT or PRV ΔgE 
(Figure 1C). PRV WT induced rapid and substantial ERK1/2 phosphorylation, whereas 
PRV ΔgE led to a less prominent ERK1/2 phosphorylation compared to WT. Hence, also 
in primary porcine T lymphocytes, PRV gE triggers ERK1/2 phosphorylation.
















Figure 1. Providing gE in trans triggers ERK1/2 phosphorylation in primary porcine T lymphocytes. (A) 
Primary porcine T lymphocytes were stimulated with gE recombinant (100 µg/ml) for different time 
points, lysed and ERK1/2 phosphorylation was detected via Western Blot. (B) ST cells were transfected 
with either a control or a gE-encoding plasmid and incubated for 48 hours. The first four lanes (left) 
correspond to primary T lymphocytes co-cultured with control-transfected ST cells; the last four lanes 
(right) correspond to T lymphocytes co-cultured with gE-transfected ST cells. After co-incubation with 
transfected ST cells for different time points, primary T lymphocytes were collected and lysed. ERK1/2 
phosphorylation was assessed via Western Blot. (C) Primary T lymphocytes were inoculated with either 
PRV WT or PRV ΔgE for different time points, collected and lysed. Figures are representative of three 
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Primary T lymphocytes can transmit PRV to susceptible cells  
To be able to determine possible biological consequences of gE-mediated ERK1/2 
phosphorylation in T lymphocytes, we first investigated whether PRV WT and PRVΔgE 
showed obvious differences in their ability to productively infect primary T lymphocytes. 
It has been described previously that the percentage of T lymphocytes productively 
infected by PRV is very low, both in vivo and in vitro (Nauwynck and Pensaert, 1994; 
Wang et al., 1988b). In line with this observation, using immunofluorescence to detect 
different viral antigens, we did not observe obvious productive infection in T 
lymphocytes upon PRV inoculation, either with PRV WT or PRVΔgE (data not shown). 
Nonetheless, despite the absence of obvious productive infection, it has been 
demonstrated that T lymphocytes isolated from PRV-inoculated pigs carry infectious 
virus and can transmit infection to other cells (Page et al., 1992). To corroborate this, 
primary T lymphocytes were inoculated with PRV WT or PRVΔgE for 24 hours. After 
citrate buffer (CB) treatment to remove extracellular infectious virus, T lymphocytes 
were co-cultivated with ST cells. At 24 hours post co-culture, the formation of plaques 
was evident, indicative for direct spread of virus from T lymphocytes to ST cells (Figure 
2A). In support of direct intercellular spread of the virus, addition of PRV-neutralizing 
antibodies to CB-treated T lymphocytes did not prevent plaque formation in the co-
cultures (Figure 2B). In agreement with the established role of gE in cell-associated 
spread in cell cultures, plaque sizes in ST cells were smaller using PRVΔgE compared to 
PRV WT, but the number of plaques was similar for both viruses (Figure 2C). Hence, 
confirming earlier reports, although PRV does not lead to obvious productive infection 
in primary porcine T lymphocytes, PRV-inoculated T cells can transmit infection to 
susceptible cells. Despite the well-established role of gE in cell-to-cell spread, this 
glycoprotein appears not to play a substantial role in transmission of infection from T 
lymphocytes to susceptible cells. 
 
 






























Figure 2. Primary T lymphocytes transmit PRV to susceptible cells. (A) Primary T lymphocytes were 
inoculated with PRV WT for 24 hours, treated with citrate buffer and co-cultured with ST cells for another 
24 hours. After co-culture, ST cells were either observed directly by light microscopy (left) or were fixed, 
permeabilized, stained for PRV antigens and observed by fluorescence microscopy (right). Typical PRV 
plaques in ST cells can be observed. (B) Primary T lymphocytes transmit PRV to susceptible cells in the 
presence of PRV-neutralizing antibodies. ST cells were inoculated directly with PRV in the absence (left) 
or presence (center) of neutralizing polyclonal anti-PRV antibodies for 24 hours, confirming the 
neutralizing capacity of the polyclonal antibodies. Primary T lymphocytes were inoculated with PRV WT 
for 24 hours, treated with citrate buffer and co-cultured with ST cells (0.5 lymphocyte/ST cell ratio) for 
another 24 hours in the presence of neutralizing antibodies (right). Size bar = 100 µm. (C) Although gE is 
necessary for cell-cell virus spread, our experiments showed no significant differences between PRV WT 
and PRVΔgE infection when inoculated T-lymphocytes were co-cultivated with ST cells, with both viruses 
causing a similar amount of plaques. However, in agreement to previous observations, infection with 
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PRV-mediated ERK1/2 signalling in primary T cells leads to cell 
aggregation and migration  
Since gE appears not to affect productive infection in T cells or virus transmission from 
T cells to susceptible cells, we investigated whether the ability of PRV gE to trigger 
ERK1/2 activation would have any biological consequences on T lymphocyte behavior. 
One of the biological consequences of ERK1/2 signalling in T cells is homotypic cell 
aggregation, which is used as readout for T cell activation, adhesion and migration 
(Layseca-Espinosa et al., 2003).  T cell aggregation was therefore assessed in primary 
porcine T lymphocytes that were exposed to either PRV WT or PRVΔgE. Aggregation was 
analysed at 24 hpi, and identified aggregates were categorized into small or large 
aggregates. When compared to mock-infected cells, PRV WT caused a significant 
increase in the formation of large aggregates (from 2% to 23%, respectively) (Figure 3), 
whereas PRVΔgE caused significantly less cell aggregates (11%). The ERK1/2 
phosphorylation inhibitor U0126 strongly reduced PRV-induced aggregation close to 
background levels (3% of large aggregates). Addition of the U0126 diluent did not visibly 
affect cell aggregate formation (data not shown). These data confirm that T cell 



































Figure 3. PRV-induced ERK1/2 activation leads to T cell aggregation. Primary T lymphocytes were 
inoculated with either PRV WT (in the absence or presence of 10 µM ERK1/2 inhibitor U0126) or PRV ΔgE 
for 24 hours. At 24 hpi, cells were analysed by microscopy and pictures were taken. Representative images 
are shown in (A). (B) Twenty random fields per condition were analysed, aggregates were measured and 
classified as large based on their surface area (see Materials and Methods). Plot depicts the average 
percentage (± SD, three independent biological replicates) of large aggregates in each condition. Different 
letters classify datasets to compare statistically significant differences (p<0.05). Significance levels: a-b: 
****, b-c: ***; a-c: **. Size bar = 100 µm. 
 
T cell aggregation is often associated with increased cellular motility (Jevnikar et al., 
2008; Pike et al., 2011). We therefore assessed whether PRV gE triggers T cell migration. 
To this end, T lymphocytes were inoculated with either PRV WT or PRV ΔgE and 
subsequently placed in a Transwell® system with a collagen-coated coverslip in the 
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migrated through the Transwell® system onto the collagen-coated coverslip were 
counted. In line with what we observed for T cell aggregation, cell migration was 
significantly increased in PRV-inoculated T lymphocytes compared to mock-inoculated 
cells (Figure 4B). PRVΔgE led to a consistent trend of decreased T cell migration 
compared to PRV WT, though not statistically significant (p value = 0.077). In line with 
what we observed for cell aggregation, addition of U0126 reduced migration of PRV-
inoculated T lymphocytes to the level seen in mock-inoculated cells. As a control, 
addition of the DMSO-based U0126 diluent did not affect cell migration (Figure 4C). To 
determine whether migrating PRV-inoculated T lymphocytes may transmit the virus to 
other cells, PRV-inoculated T lymphocytes that migrated to the bottom chamber of the 
Transwell® system were treated with citrate buffer to remove extracellular virus. 
Subsequent co-cultivation with ST cells resulted in obvious infection of the ST cells, 
indicating that migrating PRV-inoculated T lymphocytes can transmit infection to 
susceptible cells (Figure 4D). Altogether, these results show that PRV triggers 
aggregation and migration of primary porcine T lymphocytes in vitro, and that these 
effects are ERK1/2-signalling dependent and partially mediated by gE.
























Figure 4. PRV-induced ERK1/2 activation leads to increased motility of T lymphocytes. Primary T 
lymphocytes were inoculated with either PRV WT (in the absence or presence of 10 µM U0126) or PRV 
ΔgE for 24 hours. (A) Afterwards, cells were placed onto a Transwell® and incubated 24 hours further to 
allow migration of the cells to the lower chamber, followed by microscopic quantification of migrated 
cells. (B) Plot shows the fold increase (mean ± SD, three independent biological replicates) in the number 
of migrated cells for the different conditions compared to mock-inoculated cells. Different letters classify 
datasets to compare statistically significant differences (p<0.05). Significance levels: a-b: *. ‘ab’ represents 
a set of data, of which, when compared to either data set ‘a’ or data set ‘b’, the statistical p-value is greater 
than 0.05. (C) Migration of PRV-inoculated primary T lymphocytes in the presence of 10 µM U0126 or 
DMSO-based diluent. Primary porcine T lymphocytes, at 24 hpi with PRV WT, were placed on a Transwell® 
and cultivated further for 24 hours to allow cell migration. Migratory cells were collected on a collagen-
coated glass insert placed on the bottom of the well (see Materials and Methods and Figure 7A). Plot 
represents mean + SD of three independent biological replicates. Different letters classify datasets to 
compare statistically significant differences (p<0.05). Significance levels: a-b: *** (D) T lymphocytes that 
had migrated to the lower chamber were treated with citrate buffer and incubated for 24 hours with ST 














































































In the previous chapter, we demonstrated that PRV gE has the previously 
uncharacterized ability to trigger ERK1/2 phosphorylation in the Jurkat T cell line. The 
present study shows that PRV activates the ERK1/2 signalling pathway in porcine T 
lymphocytes and gE again contributes to this ERK1/2 activation. Moreover, PRV-
mediated ERK1/2 activation in primary porcine T lymphocytes results in T cell 
aggregation and migration, which is in part mediated by gE. 
Primary porcine T lymphocytes have been reported before to display limited 
susceptibility to productive PRV infection in vitro and in vivo (Nauwynck and Pensaert, 
1994; Wang et al., 1988b). Still, co-cultivation of T lymphocytes isolated from PRV 
infected pigs with highly susceptible cells resulted in the formation of plaques, indicating 
that T lymphocytes may function as carrier cells to transmit virus to susceptible cells 
(Page et al., 1992). We confirmed these earlier findings in vitro in primary T lymphocytes. 
In our assays, no differences in transmission efficiency of virus from T lymphocytes to ST 
cells were observed between PRV WT and ΔgE inoculations, suggesting that gE (and gE-
mediated ERK1/2 signalling) does not substantially contribute to this process. Despite 
this, gE and ERK1/2 signalling were found to significantly affect T lymphocyte behavior. 
Homotypic T cell aggregation correlates with T cell activation. Formation of T cell 
aggregates upon contact with either infected cells or virus has been described before 
(Takahashi et al., 2002; van Velzen et al., 2013). PRV WT caused a strong increase in T 
lymphocyte aggregation, whereas PRV ΔgE was significantly impaired in triggering cell 
aggregation. As others before, we observed that T cell aggregation depends on ERK1/2 
signalling (Guo et al., 2014; Layseca-Espinosa et al., 2003), as the addition of an inhibitor 
of ERK1/2 signalling abrogated the formation of large aggregates.  T cell aggregation has 
been described to correlate with T cell migration (Jevnikar et al., 2008; Pike et al., 2011). 
Other viruses, like Human T-lymphotropic Virus 1 (HTLV-1) and the betaherpesvirus 
Human Cytomegalovirus (HCMV), trigger migration of virus-inoculated leukocytes 
(Chevalier et al., 2014; Smith et al., 2004). In the current report, PRV inoculation also 
resulted in an increased migration of T lymphocytes. In line with our results on T cell 
aggregation, gE contributed to some extent to PRV-induced migration of T lymphocytes 
and inhibition of ERK1/2 signalling abrogated migration. Nevertheless, residual ERK1/2 




signalling, T cell aggregation and T cell migration could be observed with PRVΔgE. This 
may indicate that additional viral proteins may be involved in these processes. 
Interestingly, other viral proteins of PRV, like US2 and UL46, have been reported to 
modulate ERK1/2 signalling in other cell types (Lyman et al., 2006; Kang and Banfield, 
2010; Schulz et al., 2014; Nogalski et al., 2013). Future research will show whether these 
or other viral proteins may also be involved in the ERK1/2-dependent processes that we 
describe here. It will also be important to consider the involvement of gI, which forms a 
hetero-dimer with gE (Whealy et al., 1993; Zuckermann et al., 1988). The gE-gI complex 
mainly acts as one functional entity, although gI is able to reach the cell surface in the 
absence of gE and vice versa (Whealy et al., 1993). Although our data using recombinant 
gE and gE-transfected cells indicate that gE, in the absence of gI, can trigger ERK1/2 
phosphorylation, it will be interesting to determine whether complex formation with gI 
affects the efficiency of ERK1/2 phosphorylation and whether gI on itself may possibly 
affect this signalling pathway.  
In our assays, migrating T lymphocytes were able to transmit PRV to ST cells. Some 
viruses utilize cells that are less permissive to viral replication as carrier cells, subverting 
antiviral signalling pathways of the host to facilitate viral spread. For instance, HIV-1 uses 
dendritic cells as transporters to reach one of its major target cell populations, CD4+ T 
cells (Cavrois et al., 2008). HCMV infects non-permissive monocytes, prompting these 
cells to migrate to target tissues, where the virus then initiates replication upon 
differentiation of the monocytes to macrophages (Smith et al., 2004). Our study shows 
that PRV, and in particular gE, activates ERK1/2 in non-permissive T lymphocytes, leading 
to an increase in homotypic T cell aggregation and migration, and that migrating cells 
are able to transmit the virus to highly susceptible cells. Hence, our results suggest a 
hypothetical novel role for ERK1/2 signalling and gE in viral spread, where (gE-mediated) 
ERK1/2 activation triggers PRV-carrying T lymphocytes to migrate and infect other cells 




















Chapter 4 : PRV gE trigger ERK1/2 phosphorylation and degradation of the pro -apoptotic  protein Bim in epithelial  cells \ 
 
PRV gE TRIGGERS ERK1/2 PHOSPHORYLATION AND 
DEGRADATION OF THE PRO-APOPTOTIC PROTEIN BIM 







Maria S. Pontes, Cliff Van Waesberghe, Hans Nauwynck, Bruno Verhasselt & Herman W. 
Favoreel 
Virus Research 213 (2016) 214–218
Chapter 4 - Pseudorabies virus glycoprotein gE triggers ERK1/2 phosphorylation and degradation 
of the pro-apoptotic protein Bim in epithelial cells 
76 
ABSTRACT 
ERK1/2 activation is generally associated with cell survival and proliferation. Activation 
of ERK1/2 may trigger anti-apoptotic responses such as the phosphorylation and 
consequent degradation of Bim, a pro-apoptotic member of the Bcl-2 protein family 
(Ewings et al., 2007; Ley et al., 2003). ERK1/2-dependent host cell survival may be 
beneficial for intracellular pathogens and different viruses have been shown to benefit 
from ERK1/2-dependent Bim degradation. In the previous chapters, we have described 
that the viral glycoprotein gE mediates PRV-induced activation of ERK1/2 in T 
lymphocytes. In the present chapter, we show that PRV gE-mediated ERK1/2 
phosphorylation also occurs in epithelial cells and that in these cells, gE-mediated 
ERK1/2 signalling is associated with the degradation of Bim. For the first time, our results 
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Apoptosis of virus-infected cells is an intrinsic anti-viral host response and consequently 
many viruses have acquired various strategies to evade this process. Large DNA viruses 
like alphaherpesviruses typically encode several proteins that interfere with apoptotic 
signalling. The alphaherpesvirus subfamily contains closely related pathogens of man 
and animal, including herpes simplex virus (HSV) and varicella-zoster virus (VZV) in man 
and pseudorabies virus (PRV) in pig. For PRV, thus far, only the viral protein US3 has 
been described to interfere with apoptotic signalling (Chang et al., 2013; Geenen et al., 
2005; Munger and Roizman, 2001; Ogg et al., 2004). 
Many viruses interact with the ERK1/2 signalling cascade as a method to control cell 
survival. The ERK1/2 signalling pathway promotes cell survival by different mechanisms 
like post-translational modification and regulation of components of the cell death 
machinery, and controlled transcription of anti- and pro-survival genes (Kolch, 2005). 
The ERK1/2 signalling pathway is the only signalling pathway so far implicated in the 
degradation of Bim, a pro-apoptotic member of the Bcl-2 protein family (Ewings et al., 
2007; Hübner et al., 2008; Ley et al., 2003; Luciano et al., 2003). Phosphorylation and 
degradation of Bim by ERK1/2 contributes to reduced sensitivity of cells to apoptosis 
(Bonni et al., 1999; Ley et al., 2004; Puthalakath and Strasser, 2002; Sheridan et al., 2008; 
Zha et al., 1996b). Bim has been shown to have a central role in the regulation of immune 
responses, particularly of cytotoxic T lymphocytes, upon chronic viral infection (Grayson 
et al., 2006; Pellegrini et al., 2003). 
We have recently described that the viral glycoprotein E (gE) of PRV, an important 
virulence factor, triggers activation of ERK1/2 in T lymphocytes (Chapters 3a and 3b). In 
the current study, we wanted to investigate whether PRV gE-mediated ERK1/2 signalling 
also occurs in epithelial cells and whether this correlates with degradation of the 
ERK1/2-regulated pro-apoptotic Bim protein.  
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MATERIALS AND METHODS 
Cells, viruses and infections 
PK15 (pig kidney) cells were grown in Eagle's minimal essential medium (MEM, Life 
Technologies) supplemented with 10% FBS, glutamine (0.3 mg/ml), and antibiotics (100 
U/ml penicillin, 0.1 mg/ml streptomycin). PRV wild type (WT, Becker strain), gEnull PRV 
91 (PRV ΔgE, (Tirabassi et al., 1997)) and PRV107, lacking the cytoplasmic domain of gE 
(gEΔcd, (Tirabassi and Enquist, 1999), were grown and titrated on PK15 cells, and stored 
at −80°C. PRV Becker and PRV 91 (PRVΔgE) were a kind gift of L. Enquist, Princeton 
University. Prior to inoculation, cells were seeded at 400,000 cells/ml and were 
inoculated with either PRV WT or the isogenic mutants PRVΔgE and PRV gEΔcd at a 
multiplicity of infection (MOI) of 2 for different time points, as indicated in the Results 
section below. To assess the involvement of ERK1/2 signalling, the ERK1/2 
phosphorylation inhibitor U0126 (100 µM, Cell Signalling) was added to the medium 30 
minutes prior to inoculation of the cells, as well as at 2 hours post inoculation (hpi) with 
PRV WT at an MOI of 2. Cells were collected 1, 4 and 6 hpi for Western Blot analysis.  
 
Western Blotting 
Cells were washed with PBS, resuspended ice-cold lysis buffer (TNE buffer, 10% NP40, 
1mM Na3VO4, 10 mM NaF, protease inhibitor cocktail) and incubated for 20 min at 4°C. 
SDS-PAGE and Western blotting were performed as described previously (Deruelle et 
al., 2007). Protein amounts of 20 μg were used for all experiments. Protein 
concentration was determined using the bicinchoninic acid (BCA) protein assay reagent 
(Thermo Scientific) according to the manufacturer's instructions. Blots were blocked in 
5% nonfat dry milk in phosphate-buffered saline (PBS)–Tween 20 for 1 h at room 
temperature and incubated with primary antibodies for 1 h or overnight (according to 
the manufacturer's instructions). After several washes in 0.1% Tris-buffered saline 
(TBS)–Tween 20 (TBS-T), blots were incubated with HRP-conjugated secondary 
antibodies for 1 h at room temperature and developed using enhanced 
chemiluminescence. Phospho-specific ERK1/2 antibody (1/1000; Cell Signalling) signal 
and Bim-specific antibody (1/1000; ab32158, Abcam), were detected with ECL Plus (GE 
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Healthcare). Total ERK1/2 antibody (1/1000; Cell Signalling) signal and viral protein 
antibody – rabbit polyclonal gE antibody (1/500), and mouse monoclonal US3 (1/500) 
and gB (1/200) antibodies – signals used as loading and infection controls, respectively, 
were detected with Pierce ECL (Thermo Scientific).  
 
Cell surface expression of gE and gB 
After inoculation with the different viruses, PK15 cells were detached from the wells 
using trypsin at different time points indicated in the Results section below. The cells 
were washed in ice cold PBS, fixed in 3% paraformaldehyde for 10 minutes at room 
temperature and finally washed twice with PBS. The cells were then resuspended in PBS 
containing primary antibody, gE (1/100; mAb 5F8, Nauwynck & Pensaert, 1995) or gB 
(1/100; mAb 1C11, Nauwynck & Pensaert, 1995), and incubated for 30 minutes at room 
temperature. After washing twice with PBS, the cells were incubated with secondary 
antibody, FITC-conjugated goat anti-mouse, for 30 minutes. Expression of gE and gB on 
the cell surface was measured by flow cytometry (FACS Canto, Beckton-Dickison 
Biosciences). As a first step, viable cells were selected using Forward Scatter (FSC)/ Side 
scatter (SSC), excluding debris and dead cells. From the population of viable cells, 
doublet discrimination was performed using FSC Height versus FSC Area and SSC Height 
versus SSC Area, ensuring only single cells are considered. Finally, mean fluorescence 
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RESULTS 
PRV gE leads to ERK1/2-dependent Bim degradation in epithelial 
cells 
To analyze whether gE PRV mediates ERK1/2 activation on epithelial cells, PK15 cells 
were inoculated either with PRV WT or PRVΔgE, for 1, 4 and 6 hours. At 6 hours post 
inoculation (hpi), PRV WT caused a pronounced increase in ERK1/2 activation, whereas 
PRVΔgE infection led to similar ERK1/2 phosphorylation levels as seen in mock-infected 
cells (Figure 1A&B). As indicated earlier, it has been reported before that ERK1/2 
signalling triggers the phosphorylation of the pro-apoptotic protein Bim, leading to its 
degradation via the proteasome (Ewings et al., 2007; Ley et al., 2003). ERK1/2-induced 
Bim modulation during alphaherpesvirus infection has only been shown for VZV (Liu and 
Cohen, 2014). Phosphorylation and consequent degradation of Bim can be identified by 
Western blot analysis via a slight increase in apparent molecular weight, followed by a 
loss of Bim detection (Ley et al., 2003). We observed that PRV WT infection triggers Bim 
degradation and that this process is suppressed in PRVΔgE-infected cells (Figure 1A&B). 
Addition of an ERK1/2 phosphorylation inhibitor (100 µM U0126) during PRV WT 
infection fully prevented Bim degradation (Figure 1C), confirming that PRV-induced 
ERK1/2 activation results in Bim degradation. Western blot analysis of viral proteins 
showed that differences in ERK1/2 phosphorylation or Bim degradation could not be 
attributed to differences in replication efficiency of PRV WT versus PRVΔgE, neither due 
to a suppressive effect of the inhibitor on virus replication (Figures 1D and 1E, 
respectively). In summary, our results show that PRV triggers gE-mediated ERK1/2 
activation in epithelial PK15 cells and that phosphorylation of ERK1/2 in these cells is 
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Figure 1. PRV gE triggers ERK1/2 phosphorylation in PK15 cells, causing degradation of Bim. (A) PK15 cells 
were either mock-inoculated or inoculated with PRV WT or PRVΔgE at an MOI of 2. At different time points 
post inoculation, cells were collected, lysed and analysed via Western blot, detecting phospho-ERK, total 
ERK and Bim. (B) ERK1/2 activation and Bim degradation detected by Western Blot were quantified by 
measuring the relative intensity of the bands (Bio-Rad Image LabTM system). (C) PK15 cells were inoculated 
with PRV WT in the presence of the ERK1/2 phosphorylation inhibitor U0126, collected and analyzed at 
different time points as indicated above. (D) Protein expression of PRV gB, US3 and gE. PK15 cells were 
D 
E 
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inoculated with PRV WT, PRVΔgE or PRV gEΔcd (MOI 2) and expression of the different viral proteins was 
detected by Western Blot. Cells infected with PRV gEΔcd express gE without cytoplasmic domain and 
therefore show a reduced gE band size. (E) Inhibition of ERK1/2 phosphorylation does not affect 
expression of PRV US3. PK15 cells were inoculated with PRV WT (MOI 2), and incubated in the presence 
or absence of the ERK1/2 phosphorylation inhibitor U0126. Expression of US3 was detected by Western 
Blot. (F) Primary porcine T lymphocytes were co-cultivated with gE-transfected ST cells as described in 
Chapter 3b. After stimulation, the T lymphocytes were carefully collected and pERK, ERK and Bim were 
detected by Western Blot. 
 
Infection with gEΔcd results in earlier ERK1/2-activation and 
Bim degradation 
In infected cells, gE, like other viral glycoproteins, is expressed in different cell 
membranes, including the plasma membrane (Favoreel et al., 2004). The cytoplasmic 
domain of PRV gE contains endocytosis motifs that retrieve the protein from the plasma 
membrane during early stages of infection (up to 6 hpi), a process with a relatively 
unclear function (Tirabassi and Enquist, 1998; Tirabassi and Enquist, 1999). Genetic 
variants of PRV that lack the cytoplasmic domain of gE (PRV gEΔcd), and therefore the 
intracytoplasmic endocytosis motifs, lose the capacity to internalize from the plasma 
membrane (Tirabassi and Enquist, 1999). Interestingly, when PK15 cells were inoculated 
with PRV gEΔcd, we could observe a more rapid ERK1/2 phosphorylation (at 4hpi) and a 
more dramatic Bim degradation at 6hpi when compared to PRV WT (Figure 2). Western 
blot analysis of viral proteins showed that differences in ERK1/2 phosphorylation or Bim 
degradation could not be attributed to differences in virus replication efficiency (Figure 
1D). Hence, whereas PRVΔgE showed an impaired ability to trigger ERK1/2 activation 
and Bim degradation, PRV gEΔcd showed an increased ability to trigger these processes 
compared to PRV WT. 
Chapter 4 - Pseudorabies virus glycoprotein gE triggers ERK1/2 phosphorylation and 




Figure 2. (A) A PRV mutant that lacks the cytoplasmic domain of gE triggers enhanced ERK1/2 
phosphoryrlation and Bim degradation. PK15 cells were inoculated with PRV WT, PRVΔgE or PRV gEΔcd at 
an MOI of 2. Cells were collected and lysed at different time points. Phospho-ERK, total ERK and Bim were 
detected by Western Blot. (B) ERK1/2 activation and Bim degradation detected by Western Blot were 
quantified by measuring the relative intensity of the bands (Bio-Rad Image LabTM system). 
 
We wanted to confirm whether there were any obvious variances in gE cell surface 
expression levels between cells inoculated with PRV WT and PRV gEΔcd that could 
contribute to understand the results described above. Infected PK15 cells were collected 
at 4 and 6 hpi, and gE expression levels at the plasma membrane were analysed using 
flow cytometry. Cell surface levels of glycoprotein B at 6 hpi were determined as a 
control. Differences in gE cell surface expression were noticeable by 4 hpi, and even 
more obvious at 6 hpi, clearly showing greater levels of gE in the plasma membrane of 
PRV gEΔcd-infected cells (Figure 3). Although further research will be required to 
investigate this mechanistically, these results appear to be in line with our findings in T 
lymphocytes (Chapter 3b), which suggested that gE-dependent ERK1/2 activation may 
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occur via interaction of the extracellular domain of cell surface-expressed gE with a 































Figure 3. Cells infected with a PRV mutant that lacks the cytoplasmic domain of gE show increased cell 
surface expression of gE. Cells were inoculated for 4 or 6 hours with PRV WT, PRVΔgE or PRV gEΔcd at an 
MOI of 2 and fixed with paraformaldehyde. Expression of cell surface gE was assessed by flow cytometry 




Chapter 4 - Pseudorabies virus glycoprotein gE triggers ERK1/2 phosphorylation and 
degradation of the pro-apoptotic protein Bim in epithelial cells 
85 
DISCUSSION 
Apoptosis of virus-infected cells is an intrinsic anti-viral host response and many viruses 
have acquired the ability to evade this process. The ERK1/2 signalling cascade promotes 
cell survival by different mechanisms (Lu and Xu, 2006), making this signalling pathway 
an ideal  target for viruses to modulate host-driven apoptosis. One of the anti-apoptotic 
mechanisms that ERK1/2 has been associated with is the phosphorylation and 
consequent degradation of Bim, a pro-apoptotic member of the Bcl-2 protein family 
(Ewings et al., 2007; Ley et al., 2003). 
In this chapter, we reveal that PRV infection leads to the sustained activation of ERK1/2 
in epithelial cells, which coincides with the phosphorylation and consequent 
degradation of Bim. VZV (Liu and Cohen, 2014) also interferes with ERK1/2-dependent 
Bim degradation, highlighting the potential importance of this signalling axis for the 
biology of the Alphaherpesvirinae subfamily. Several other viruses have also been 
described to trigger Bim degradation in an ERK1/2-dependent manner, like the 
gammaherpesvirus Epstein-Barr virus (EBV) and the Human T-cell leukaemia type 1 virus 
(HTLV1) (Clybouw et al., 2005; Higuchi et al., 2014; Trushin et al., 2012). Aside viral 
factors that trigger ERK1/2-mediated Bim degradation, some viruses (including EBV, 
Kaposi’s Sarcoma-associated herpesvirus (KSHV) and vaccinia virus) also encode 
proteins that directly bind and sequester Bim, thereby interfering with its activity 
(Campbell et al., 2014; Choi et al., 2012; Desbien et al., 2009). On the contrary, 
adenovirus infection has been associated with Bim upregulation and consequent virus-
mediated cell death (Subramanian et al., 2007). Moreover, infection with HIV 1 triggers 
Bim-mediated apoptosis by interference of the Tat protein with the cell microtubule 
dynamics (Chen et al., 2002); additionally, the binding of gp120 protein with its partner, 
CXCR4, leads to the upregulation of Bim (Trushin et al., 2012). This multitude of 
strategies to interfere with Bim activity indicates that this pro-apoptotic protein possibly 
represents a pivotal player in the biology and pathogenesis of many viruses. 
As demonstrated in the previous chapters for T lymphocytes, we show that also in 
epithelial cells, PRV gE is associated with PRV-triggered ERK1/2 activation. Furthermore, 
our data indicate that in this cell type, gE-triggered ERK1/2 phosphorylation appears to 
be associated with the degradation of Bim, linking gE with the apoptosis signalling 
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network for the first time. In support of the hypothesis that gE may trigger these 
signalling events, infection with a PRV mutant encoding an endocytosis-defective gE 
variant (gEΔcd PRV) showed higher plasma membrane levels of gE, earlier ERK1/2 
phosphorylation and Bim degradation, when compared to infection with PRV WT. 
Noticeably, gE-mediated ERK1/2 phosphorylation did not cause Bim degradation in 
primary porcine T lymphocytes (Figure 1F), pointing out that PRV-induced ERK1/2 
activation may trigger different down-stream events depending on the cell type. 
In conclusion, our study illustrates a potential novel link between gE and the anti-
apoptotic properties of PRV. To this date only the US3 viral kinase had been reported to 
inhibit programmed cell death during PRV infection (Deruelle et al., 2007; Geenen et al., 
2005; Ogg et al., 2004) Additionally, our results are in line with the hypothesis that gE 
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Viruses are highly competent in hijacking and redirecting various signalling pathways of 
the host cell machinery, ensuring successful virus replication and propagation. One 
signalling pathway that has been widely studied in the context of viral manipulation of 
the host is the ERK1/2 signalling cascade. This central signalling pathway coordinates a 
myriad of cellular events, making it an attractive target for viruses to manipulate for 
their own benefit.  
Being able to establish life-long infections, herpesviruses excel at effective host 
manipulation. Many herpesviruses have been reported to interfere with the ERK1/2 
signalling pathway, and this signalling cascade seems to play a role at different stages of 
the life cycle of these viruses. Some herpesviruses activate ERK1/2 at a very early stage 
during infection, which seems to contribute to viral entry (HSV-1, KSHV, HCMV) 
(Naranatt et al., 2003; Sharma-Walia et al., 2005; Reeves et al., 2012; Zheng et al., 2014) 
and replication (HSV-1, HSV-2, VZV, HCMV, KSHV) (Rodems and Spector, 1998; Smith et 
al., 2000; Chen and Stinski, 2002; Kuang et al., 2009; Liu et al., 2012; Torres et al., 2012; 
Fu et al., 2015). ERK1/2 activity also seems to take part in viral-induced protection 
against apoptosis (HSV-2, VZV, HCMV, EBV) (Perkins et al., 2003; Clybouw et al., 2005; 
Wang et al., 2006; Oussaief et al., 2009; Liu et al., 2012; Reeves et al., 2012; Iwakiri et 
al., 2013; Liu and Cohen, 2014; Li et al., 2015), either by suppressing pro-apoptotic 
molecules or activating anti-apoptotic agents. The establishment of latency is a major 
characteristic of herpesviruses, which makes these viruses highly successful pathogens. 
ERK1/2 has been shown to be involved in both establishing of and reactivation from 
latency for some herpesviruses (HCMV, KSHV) (Ford et al., 2006; Reeves and Compton, 
2011). Being a key signalling pathway in tumour growth, some tumour-inducing 
herpesviruses activate ERK1/2 to induce cell proliferation, malignant transformation, 
migration and cell invasiveness (MDV, EBV, KSHV) (Roberts and Cooper, 1998; Dawson 
et al., 2008; Meckes et al., 2010; Qin et al., 2013; Subramaniam et al., 2013).  
Pseudorabies virus (PRV) has been shown to activate ERK1/2 in infected epithelial cells 
(Lyman et al., 2006; Kang and Banfield, 2010; Schulz et al., 2014), and the viral UL46 
protein has been shown to play a role in this process (Schulz et al., 2014). Also in 
fibroblasts PRV was shown to activate ERK1/2; additionally, the PRV protein US2 was 
described to bind and sequester activated ERK1/2, targeting the kinase to the plasma 
membrane and therefore inhibiting its nuclear translocation (Kang and Banfield, 2010; 
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Lyman et al., 2006). The present thesis reports new insights on the modulation of the 
ERK1/2 signalling pathway by PRV. Here we reveal the contribution of the viral 
glycoprotein E (gE) in PRV-induced ERK1/2 activation and provide hints on the 
mechanism used by gE to modulate this central signalling pathway. Additionally, we 
describe physiological consequences linked to PRV gE-mediated ERK1/2 activation in 
two different cell types, T lymphocytes and epithelial cells.  
 
The role of gE in PRV-induced ERK1/2 activation 
One of the first PRV envelope proteins to be described (Hampl et al., 1984), gE is not 
essential for the replication (in vitro or in vivo) of PRV or other alphaherpesviruses (HSV-
1, EHV-1, BHV-1), except for VZV (Engelenburg et al., 1995; Flowers and O’Callaghan, 
1992; Jacobs, 1994; Longnecker and Roizman, 1986; Neidhardt et al., 1987). Albeit not 
essential in the replication of most alphaherpesviruses, gE is conserved among the 
different subfamily members, controlling important aspects of these viruses’ 
pathogenesis. Most noticeably, gE is a determining factor in mediating full virulence 
during animal infections (Card and Enquist, 1995; Card et al., 1992; Jacobs et al., 1993b; 
Kimman et al., 1992; Lomniczi et al., 1984; Mettenleiter et al., 1987) and cell-to-cell 
spread in polarized cells or in cells that form extensive junctions with one another (i.e., 
keratinocytes, epithelial cells, and neurons) (Dingwell and Johnson, 1998; Dingwell et 
al., 1995; Enquist et al., 1998; Mettenleiter et al., 1987; Tirabassi and Enquist, 1998; 
Wisner et al., 2000; Zsak et al., 1992). Other functions that have been reported are 
involvement in virion assembly (Brack et al., 2000) and species-specific Fcγ receptor-like 
activity, with gE binding immunoglobulin G (IgG) at their Fc domain (Favoreel et al., 
1997; Johnson et al., 1988; Litwin et al., 1992).  
The present thesis demonstrates that gE is a key viral factor in PRV-induced activation 
of the ERK1/2 signalling cascade and that gE-mediated ERK1/2 activation does not 
depend on the glycoprotein´s C-terminal (cytoplasmic) domain. This observation was 
surprising, as up until recently, cellular signalling mediated by gE was invariably 
associated with its cytoplasmic region. In fact, the cytoplasmic region of gE contains 
tyrosine motifs that once phosphorylated upon antibody-mediated crosslinking may 
trigger capping of viral glycoproteins (Desplanques et al., 2007; Favoreel et al., 1997). 
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Capping can be observed in leukocytes upon crosslinking of immunoreceptors, and 
typically leads to leukocyte activation (D’Ambrosio et al., 1996). Additional experiments 
described in Chapters 3a and 3b, where we provided gE in trans, confirmed that the N-
terminal (extracellular) domain is required and sufficient for ERK1/2 phosphorylation. 
How is gE able to activate ERK1/2 via its extracellular region? This question prompted 
us to speculate that this glycoprotein may bind to one (or more) cellular receptor(s), 
likely present on the cell membrane. A cellular interaction partner for the extracellular 
domain of gE has only been reported for VZV, namely the insulin-degrading enzyme (Li 
et al., 2006), but not for any of the other alphaherpesviruses, including PRV.  
The lentivirus HIV-1 is frequently associated with MAPK signalling modulation (Furler 
and Uittenbogaart, 2010), particularly through its gp120 envelope protein, and previous 
reports have linked HIV-1/gp120-triggered ERK1/2 activation to the chemokine receptor 
CXCR4 (Kinet et al., 2002; Popik and Pitha, 1996; Popik et al., 1998; Trushin et al., 2012). 
Gp120-CXCR4 signalling events affects entry and post-entry stages of infection and may 
modulate cellular functions even in the absence of infection (Borghi et al., 1995; Merrill 
et al., 1992; Shiratsuchi et al., 1994). CXCR4 is a 7-transmembrane G-protein coupled 
receptor originally identified in peripheral blood leukocytes (Federsppiel et al., 1993; 
Nomura et al., 1993; Loetscher et al., 1994) and later described as essential for T-cell 
tropic HIV-1 entry and for HIV-induced signal transduction (Deng et al., 1996; Feng et al., 
1996; Popik and Pitha, 1996). Presently, CXCR4 is reported to be expressed on the 
surface of a variety of cell-types like T cells (Bleul et al., 1996; Bleul et al., 1997), B cells 
(Honczarenko et al., 1998), macrophages (Simmons et al., 1998; Verani et al., 1998; Yi et 
al., 1998) epithelial and endothelial cells (Gupta et al., 1998; Murdoch et al., 1999), and 
neurons from both the central and peripheral nervous systems (Dwinell et al., 1999; 
Murdoch, 2000; Ghosh et al., 2012; Hesselgesser et al., 1997). This chemokine receptor 
is also described to play a pivotal role in several physiological processes such as 
hematopoiesis, neurogenesis, germ cell development, cardiogenesis, vascular formation 
and cell migration (Agarwal et al., 2010; Cui et al., 2013; Ghosh et al., 2012; Moser and 
Loetscher, 2001; Murphy, 1994; Richardson and Lehmann, 2010; Sainz and Sata, 2007; 
Zhou et al., 1995).  
The ability of CXCR4 to modulate the ERK1/2 signalling pathway has not only been 
described in the context of HIV/gp120, but also of its interaction with its most known 
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physiological ligand, the stromal cell-derived factor 1 (SDF-1 or CXCL12), where CXCR4-
triggered ERK1/2 activation has been shown to lead to cell migration in T and B 
lymphocytes and myeloid cells (Alsayed et al., 2007; Gorter et al., 2008; Kremer et al., 
2013). Considering this, we have begun to explore whether CXCR4 may be involved in 
gE-mediated ERK1/2 phosphorylation and preliminary results are encouraging (Figure 
1).  
 






Figure 1 – CXCR4 appears to be involved in PRV gE-mediated ERK1/2 activation (A) Using similar 
methodology as in Chapter 3b, primary porcine T lymphocytes were incubated with epithelial cells 
transiently transfected with gE, in the presence or absence of the CXCR4 antagonist AMD3100. As a 
control we used a GFP-expressing plasmid (pcDNA-GFP, made in house) (B) Parental and CXCR4-
expressing U87 cells were incubated with PRV or PRVΔgE, or mock-inoculated. In both experiments, cell 
lysates were prepared, and ERK1/2 activation was detected using Western Blot. 
 
Firstly, by pre-incubating primary T lymphocytes with the CXCR4 antagonist AMD3100 
(Schols et al., 1997; Donzella et al., 1998), we observed that gE-mediated ERK1/2 
activation was impaired (Figure 1.A). In a second set of experiments, we used two cell 
lines, U87 cells (parental astrocyte cell line, which does not express CXCR4) and U87 cells 
stably transfected with CXCR4 (U87.CXCR4) (kindly provided by Dr. Dominique Schols, 
Rega Institute, Leuven). In U87.CXCR4, inoculation with PRV WT led to an increase in 
ERK1/2 phosphorylation, whereas inoculation with PRVΔgE caused a less pronounced 
effect on ERK1/2 phosphorylation. As a control, we observed no differences in ERK1/2 
activation levels in mock- or virus-infected parental U87 cells (Figure 1.B).  
The potential involvement of CXCR4 in gE-mediated ERK1/2 signaling would be in line 
with the notion that CXCR4 is a particularly attractive target for viruses. Indeed, in a 
noteworthy review (Arnolds and Spencer, 2014), the authors point out that amongst the 
well-documented exploitation by pathogens of host chemokines and chemokine 
receptor functions (Holst and Rosenkilde, 2003; Lalani and McFadden, 1999; Liston and 
McColl, 2003; Murphy, 2001; Sodhi et al., 2004), CXCR4 in particular appears to be a 
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prime target for manipulation by a number of different viruses. Besides HIV/gp120 as 
explained higher, several other viruses like herpesviruses, poxviruses, and 
papillomaviruses, have been found to interact with CXCR4, altering the receptor´s 
expression or functional activity. This has direct effects on cell trafficking, immune 
responses, cell proliferation, and cell survival (Arnolds and Spencer, 2014). For 
herpesviruses, HSV-1 infection of mature dendritic cells caused a decrease of protein 
levels of CXCR4 on the cell surface (Prechtel et al., 2005); although the mechanism for 
the down-regulation of CXCR4 during HSV-1 infection remains unknown. Also for EBV, 
studies have indicated viral manipulation of CXCR4. EBV-infected primary B lymphocytes 
displayed a decrease in CXCR4 expression, and this correlated with decreased migration 
toward SDF-1 (Ehlin-Henriksson et al., 2006). Additionally, transformation of a B-cell line 
with either LMP1 or EBNA2 also resulted in down-regulation of CXCR4 (Nakayama et al., 
2002). For Human Cytomegalovirus (HCMV), two viral proteins (UL33 and UL78) were 
found to interact directly with CXCR4, interfering with the function of the receptor 
(Tadagaki et al., 2012). In that report, the authors also show that UL33 and UL78 
modulate CXCR4 surface expression in the THP-1 monocytic cell line, as well as 
modulation of cellular migration.  
However promising our initial results on the involvement of CXCR4 in gE-mediated 
ERK1/2 activation may appear, further research is necessary to assess whether gE 
(in)directly binds to CXCR4, thereby resulting in ERK1/2 activation. Later in this chapter 
we elaborate further on future prospects. 
 
PRV-mediated ERK1/2 activation in T lymphocytes 
Members of the Herpesviridae family are highly successful in manipulating the immune 
system. (Adhikary et al., 2006; Arvin et al., 2010; Smith et al., 2004; Wiertz et al., 2007; 
Zerboni et al., 2014b). The interaction between herpesviruses and immune cells of the 
host can lead to modulation of specific intracellular signalling pathways and subsequent 
changes in cellular behaviour which benefit viral infection.  
In Chapters 3a and 3b, we describe that PRV gE triggers ERK1/2 activation in T 
lymphocytes, leading to homotypic aggregation, a sign of T cell activation (Guo et al., 
2014; Layseca-Espinosa et al., 2003). Homotypic T cell aggregation is often associated 
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with increased cell motility (Jevnikar et al., 2008; Layseca-Espinosa et al., 2003; Pike et 
al., 2011). In line with this, our data showed that PRV gE-triggered ERK1/2 activation 
resulted in an increased T cell migration. It has also been shown for other viruses, like 
Human T-lymphotropic Virus 1 (HTLV-1) and the betaherpesvirus Human 
cytomegalovirus (HCMV), that virus-inoculated leukocytes show increased motility 
(Chevalier et al., 2014; Smith et al., 2004).  
Previous reports described that PRV is not able to replicate efficiently in primary porcine 
T lymphocytes (Nauwynck and Pensaert, 1995b; Wang et al., 1988b). However, some 
viruses can manipulate and utilize less permissive cells as carriers to facilitate viral 
spread across the host. Viruses like HIV-1 and HCMV use dendritic cells and monocytes, 
respectively, as transporters in order to reach and carry out a successful replication in 
their primary target or more permissive environments (Cavrois et al., 2008; Smith et al., 
2004). Consistent with these observations, we describe in the present thesis that 
apparently uninfected migratory T lymphocytes can transmit the virus to epithelial cells, 
where the virus replicates with higher efficiency. It is not the first time that cell-
associated spread of infection is described for PRV, as the virus may use other blood 
cells, like monocytes, as carriers to disseminate infection across the host (Nauwynck and 
Pensaert, 1995b; Page et al., 1992; Van de Walle et al., 2003a; Van de Walle et al., 
2003b). During PRV infection, monocytes support a full cycle of replication, and are able 
to survive for some time in the bloodstream of the infected animal, even in vaccination-
immune animals (Nauwynck and Pensaert, 1992). The latter may be due to virus-induced 
capability of internalizing PRV-specific antibodies bound to viral proteins expressed in 
the cell membrane of monocytes, thereby avoiding antibody-mediated cell lysis (Van de 
Walle et al., 2003a). Additionally, these immune-masked PRV-infected monocytes are 
able to transmit the virus to endothelial cells (Van de Walle et al., 2003b). In the present 
thesis, we suggest that PRV gE-induced ERK1/2 activation and consequent migration of 
T lymphocytes could be important for PRV pathogenesis; the virus may be using these 
cells as carriers alongside infected monocytes to spread throughout the host. Cell-
mediated spread of PRV in the blood of infected animals may allow the virus to reach 
other replication sites more efficiently, such as the reproductive system. It has been 
observed in pregnant sows that PRV infection may cause reproductive failure, including 
abortion, stillbirths and mummified foetuses (Akkermans, 1976; Baskerville, 1973), and 
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that this can be facilitated by cell-mediated viremia of the virus (Nauwynck and 
Pensaert, 1992).  
Viral interaction with T lymphocytes during alphaherpesvirus infection has also been 
reported for VZV and HSV, human alphaherpesviruses closely related to PRV. VZV, 
initially classified as a neurotropic herpesvirus, has been described to mainly show T cell 
tropism. Unlike PRV, VZV efficiently infects T cells, particularly tonsil T cells that express 
skin homing markers, triggering T cell-mediated viral transport from the initial site of 
inoculation to the skin (Arvin et al., 2010; Zerboni et al., 2014b). For HSV, virus-positive 
T lymphocytes have been detected in skin grafts from lesions of patients (Aubert et al., 
2009). HSV has evolved the ability to enter and infect T lymphocytes, although these 
cells may not support efficient viral replication (Westmoreland, 1978; Sloan and Jerome, 
2007; Aubert et al., 2009). Nevertheless, infection by HSV profoundly modulates T-cell 
receptor (TCR) signalling which hinders T-cell cytotoxic function (Sloan and Jerome, 
2007; Sloan et al., 2003; Sloan et al., 2006) and alters cytokine production profiles 
toward an IL10-dominated immunosuppressive phenotype (Sloan and Jerome, 2007). 
Regarding PRV, we have observed that, in infected Jurkat T cells, the virus modulates 
CD3/TCR-induced ERK1/2 activation (Chapter 3a) but preliminary observations indicated 
no significant variations in IL10 secretion between mock and PRV WT-infected cells 
(Figure 2). However, when using a gE-deleted PRV, there was a significant decrease in 
secreted levels of this anti-inflammatory cytokine. Although speculative at this stage, 
these data possibly indicate that, via gE and possibly its effect on ERK1/2 
phosphorylation, PRV actively maintains a steady-state level of IL10 secretion, perhaps 
aiding in virus evasion from a pro-inflammatory antiviral response of the host. Future 
experiments are necessary to understand whether the observed effect is indeed driven 
by gE-mediated modulation of ERK1/2 activation, for example by using an inhibitor of 
ERK1/1 phosphorylation, like U0126. 
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Figure2 - Jurkat T-cells were inoculated with PRV WT, PRVΔgE or PRV gEΔcytoplasmic domain (PRV 107) 
for 36h or 48h. Medium was analysed using ELISA to detect the levels of the anti-inflammatory cytokine 
IL10 secreted by the cells. Plot depicts mean concentration (± SD, three independent replicates); * 
represents statistically significant differences (p<0.05). Statistical analysis was performed on GraphPad 
Prism 5 (GraphPad Software, Inc). Data sets (n=3) were analysed using One-way ANOVA (p<0.05) 
combined with Tukey’s Multiple Comparison Test (95% confidence interval). 
  
PRV-mediated ERK1/2 activation in epithelial cells 
When infected by a virus, host cells often undergo programmed cell death in an attempt 
to abort viral production and spread. It is therefore not surprising that many viruses have 
evolved mechanisms to modulate host cell apoptosis. In chapter 4 we demonstrate that 
PRV infection leads to the sustained activation of ERK1/2 in epithelial cells, which 
coincides with the phosphorylation and consequent degradation of pro-apoptotic BH-3 
only protein Bim. We also show that, similarly to ERK1/2 activation in T lymphocytes, 
the process of ERK1/2-dependent Bim degradation is associated with PRV gE. The effect 
of ERK1/2 signalling on Bim degradation is in line with other reports, showing that Bim 
is phosphorylated by activated ERK1/2 and targeted for degradation, which contributes 
to reduced sensitivity of cells to apoptosis (Bonni et al., 1999; Ewings et al., 2007; Hübner 
et al., 2008; Ley et al., 2004; Marani et al., 2004; Sheridan et al., 2008; Zha et al., 1996b). 
Bim is an important initiator and regulator of the intrinsic pathway of the apoptotic 
signalling network, interacting with the anti-apoptotic Bcl-2 proteins as well as the 
multidomain pro-apoptotic effectors. It has been demonstrated that ERK1/2 is an 
important regulatory factor of Bim, as ERK1/2-dependent phosphorylation of Bim 
promotes Bim dissociation from anti-apoptotic Bcl‑2 proteins (Ewings et al., 2007; 
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degradation by the proteasome (Ley et al., 2003; Luciano et al., 2003). To date, the only 
signalling pathway implicated in targeting Bim for ubiquitination and degradation is the 
ERK1/2 pathway; however, the specific details of how this is achieved are not known 
(Ewings et al., 2007). Given the specificity of the regulation of Bim, together with its 
important role within the apoptotic pathway, it may come as no surprise that some 
viruses target this particular signalling route. Viruses like VZV, EBV and HTLV-1 virus have 
been shown to manipulate ERK1/2 for Bim regulation (Clybouw et al., 2005; Higuchi et 
al., 2014; Liu and Cohen, 2014). 
Our study demonstrates therefore a possible novel link between gE and the anti-
apoptotic properties of PRV. To this date only the US3 viral kinase had been reported to 
inhibit programmed cell death during PRV infection (Geenen et al., 2005; Ogg et al., 
2004). Studies, including from our group, have demonstrated that US3 mediates the 
phosphorylation and subsequent degradation of another Bcl-2 family member, the pro-
apoptotic protein Bad, in PRV-infected epithelial cells (Ogg et al., 2004; Geenen et al., 
2005; Deruelle et al., 2007; Deruelle et al., 2010), which likely contributes to the anti-
apoptotic role of US3 during PRV infection. Additionally, in a more recent study, US3 has 
been shown to activate Akt and NF-ƙB anti-apoptotic signalling pathways (Chang et al., 
2013).  
Together with previous research, our data indicate that PRV encodes at least two 
proteins that interfere with the apoptotic signalling network. This is not a surprise, as 
several viruses encode multiple viral proteins that interfere with programmed cell 
death. As an example, HSV-1 encodes several proteins associated with preventing 
premature cell death. The viral proteins/transcripts US3, LAT, gJ, gD, ICP4, ICP22 and 
ICP27 were demonstrated to have anti-apoptotic activity during viral infection (Nguyen 
and Blaho, 2007). Similarly, the HIV-1 proteins Nef, Tat and Vpr have been shown to use 
different strategies to interfere with the highly complex apoptotic network (Cummins 
and Badley, 2010). The diversity of anti-apoptotic mechanisms developed by (persistent) 
viruses underscores that it is likely of paramount importance for these viruses to target 
several and/or different checkpoints of the apoptotic network.  
Additional research is necessary to understand the implications of gE-associated Bim 
degradation during PRV infection, particularly in protecting the infected cell from 
apoptosis. Unfortunately, the redundancy in viral anti-apoptotic proteins complicates 
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studies to address the importance of preventing premature host cell death in virus 
infection and pathogenesis. For example, studies using a US3-deleted PRV did not 
demonstrate conclusive data regarding the anti-apoptotic activity of US3 on virus titers 
in cell culture (Deruelle et al., 2010). One of the potential explanations for this 
observation was that, while US3 at the time was the only identified anti-apoptotic PRV 
protein, it was hypothesized that PRV may encode additional anti-apoptotic proteins 
with (partially) redundant or overlapping activity (Deruelle et al., 2010). Our current 
data, which indicate that PRV gE also modulates apoptotic cell signalling, are in support 
of this hypothesis.  
 
ERK1/2 signalling: the complexity of a tightly regulated cascade 
An increasing amount of evidence has shown that cellular signalling pathways are not 
simply ‘on-off’ switches, and that spatiotemporal properties are important in 
determining the downstream effects of these pathways. The ERK1/2 signalling cascade 
represents remarkably well this concept. As previously mentioned, this signalling 
pathway controls an array of cellular events and physiological responses to ERK1/2 
activation vary greatly depending on a range of factors. 
Cellular response to ERK1/2 signalling has been shown to depend on the cell type as well 
as on the strength and duration of ERK1/2 activation. Differences in strength and 
duration of ERK1/2 signalling are determined by factors such as cell-surface receptor 
density, expression of scaffolding proteins, the surrounding extracellular matrix, and the 
interplay between kinases and phosphatases (Murphy and Blenis, 2006; Murphy et al., 
2002). Throughout our research, we could observe differences in duration of gE-
mediated ERK1/2 activation. In Jurkat T cells, gE-dependent ERK1/2 activation during 
productive infection appeared to be continuous for several hours, whereas adding 
recombinant gE triggered transient ERK1/2 activation. We speculate here that 
apparently sustained activation of ERK1/2 in Jurkat T cells could in fact be the result of 
dynamic cell-cell interactions; infected gE-expressing Jurkat T cells may establish several 
transient homotypic contact with different cells during a given time period (Hugues et 
al., 2004; Sabatos et al., 2008), and these dynamic interactions between cells may cause 
gE to bind (and detach) repeatedly to its possible receptor. As a result, it may be possible 
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to observe an almost continuous repetitive, rather than truly sustained, ERK1/2 
activation. On the other hand, binding of recombinant gE led to a rapid but transient 
activation, possibly due to the non-dynamic nature of the interaction. We speculate that 
once bound, gE recombinant may remain attached, preventing binding of soluble gE still 
present in the medium.  
Differences in gE-mediated ERK1/2 activation in infection-permissive cells (e.g. porcine 
epithelial cells and Jurkat T cells) versus cells that show weak susceptibility to infection 
(e.g. primary porcine T lymphocytes) may also be influenced by the possible effect of 
other viral factors that are expressed during infection of permissive cells. Successful 
expression of other viral proteins during PRV infection may further influence 
downstream ERK1/2 regulation and consequent cellular responses. In particular, PRV 
US2 was described to bind and sequester ERK1/2, inhibiting its nuclear translocation 
(Kang and Banfield, 2010; Lyman et al., 2006). Subcellular location of activated ERK1/2 
has been described as an important regulating factor contributing to the cellular 
physiological response to ERK1/2 signalling.  Spatial distribution of ERK1/2 can be 
regulated by scaffold proteins, which can impede ERK1/2 nuclear translocation and 
consequent phosphorylation of its nuclear substrates (Ebisuya et al., 2005; Kolch, 2005; 
Sharrocks, 2006; Shaul and Seger, 2007; Stork, 2002).  
It would be interesting to conduct future experiments in order to understand how 
ERK1/2 is activated and regulated during PRV infection, including its subcellular 
localization, using our and other cellular models. The central role of the ERK1/2 signalling 
pathway in general cell biology aligned with the extensive research focused on this 
pathway in the various fields could provide valuable insights for future cell-focused 
antiviral treatments. 
 
GENERAL REMARKS, WEAKNESSES AND FUTURE PROSPECTS 
A novel function for Glycoprotein E 
The data presented in this thesis show that PRV activation of the ERK1/2 signalling 
cascade is mediated by gE in at least two cell types, revealing a new aspect of the role 
of this glycoprotein in the biology of PRV.  
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For the past years, the role of gE in (neuronal) spread has been studied and characterized 
(Enquist et al., 1998; Kramer and Enquist, 2013); how gE drives PRV virulence remains, 
however, largely unknown. Neuronal spread and virulence were thought to be 
correlated at first, however studies came to reveal that these gE-associated events are, 
at least partially, regulated independently (Card et al., 1992; Rinaman et al., 1993; 
Tirabassi et al., 1997; Whealy et al., 1993). Given the central role of the ERK1/2 signalling 
pathway in many key cellular events, it is tempting to assume that this signalling 
pathway may play a part in driving gE-associated virulence. Additional research is 
required to consolidate the contribution of gE-mediated ERK1/2 in the context of PRV 
infection; however, novel aspects revealed by our work may contribute to fully 
understand the involvement of gE in disease progression.  
We describe here that gE induces ERK1/2-mediated migratory behaviour in virus-
carrying T lymphocytes, which are then capable of infecting cells more susceptible to 
virus replication. Due to the continuous trafficking of lymphocytes through blood, 
lymphoid organs and non-lymphoid tissue (Jalkanen et al., 1986; Mackay, 1993; Wiedle 
et al., 2001), the virus may have found in T lymphocytes an effective vehicle to 
disseminate through the host. This hypothesis may be further elucidated by 
understanding the migratory pattern of PRV-infected T lymphocytes. Future 
experiments may include measuring the expression of specific membrane markers on 
these cells. Upon activation, T lymphocytes may be induced to express a unique set of 
adhesion molecules and chemokine homing receptors, so that primed T cells acquire the 
ability to interact with organ-specific endothelial cells and migrate to distinct target 
tissues (Fu et al., 2016; Jalkanen et al., 1986). The migratory behaviour of T lymphocytes 
is greatly influenced by their surrounding microenvironment (Butcher and Picker, 1996; 
Wiedle et al., 2001), in combination with cell activation. As in many in vitro systems, our 
experiments excluded the presence of a surrounding microenvironment containing 
soluble factors (like chemokines and other cytokines), as well as possible interactions 
with other cells (such as antigen-presenting cells). Performing similar marker analysis in 
T lymphocytes isolated from infected animals could potentially provide valuable 
information to bridge the gap between an in vitro and an in vivo set up regarding the 
behaviour of T lymphocytes.  
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We also describe that gE induces ERK1/2-mediated degradation of pro-apoptotic Bim, 
hence potentially being involved in cell survival. The next step in this research is to test 
for protection of infected cells from stimulus-induced apoptosis, possibly by measuring 
specific apoptosis markers, such as cleaved caspase-3. However, such experiments 
should consider the demonstrated effect of US3 in protecting PRV-infected cells against 
apoptosis, which may complicate determining the true effect of gE. A PRV mutant 
including a double deletion of gE and US3 could be used as a tool for testing the role of 
gE in preventing premature host cell death. While transfecting epithelial cells with gE 
could also be regarded as a promising path forward, this method would bring additional 
challenges. Widely used liposome-based DNA carriers may induce a cellular stress 
response, including expression of genes engaged in vital cellular functions, mostly 
maintaining cellular metabolism, cell cycle control and progression, and apoptosis 
(Fiszer-Kierzkowska et al., 2011; Kim and Eberwine, 2010). In consequence, the effect of 
gE in ERK1/2 signalling may be masked, leading to a false result. A preliminary evaluation 
on different transfection methods would be useful to define future research. On a 
molecular scale, further investigating Bim interactions with its partners could also 
provide a good indication of the true effect of gE-mediated ERK1/2 signalling. 
Interestingly, earlier onset of ERK1/2 activation in infected epithelial cells appeared to 
correlate with higher gE cell surface expression levels. If higher levels of gE surface 
expression lead to a putative anti-apoptotic phenotype, we questioned why would this 
glycoprotein be retrieved from the cell surface at early stages of infection. The role for 
endocytosis of gE remains unclear to this point. Tirabassi and Enquist have 
demonstrated that, in similarity to other glycoproteins, gE is internalized from the 
plasma membrane of infected cells early in infection (up to 6 hours post inoculation). 
The cytoplasmic domain of PRV gE contains endocytosis motifs which are responsible 
for the endocytosis of gE. Earlier reports had speculated that glycoproteins expressed in 
the cell surface would be preferentially incorporated in the virion envelope, but the 
aforementioned authors did not find any evidence that would support this line of 
thought. By engineering the PRV mutant that lacks the cytoplasmic domain of gE (gEΔcd, 
Tirabassi and Enquist, 1999), and studying the impact of this mutation on the virus life 
cycle, the authors could not find any obvious role for the endocytosis of gE. Considering 
these earlier studies and our observations, we suggest that PRV may use endocytosis to 
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regulate the signalling properties of gE. Signalling of plasma membrane receptors can 
be regulated by endocytosis at different levels, including receptor internalization 
(Barbieri et al., 2016; Cendrowski et al., 2016). Even if highly speculative, the binding of 
gE to its putative receptor may trigger the phosphorylation of the endocytosis motifs 
present in the cytoplasmic region, initiating the endocytic pathway. 
As the interference of gE with the ERK1/2 signalling pathway has been observed in at 
least two different cell types, it would be interesting to understand whether this effect 
is seen in other relevant cell types. Very recently, our lab has described that gE inhibits 
the activation of plasmacytoid dendritic cells (pDC) and that this phenomenon is related 
to gE’s ability to modulate ERK1/2 signalling (Lamote et al., 2017). Moreover, given their 
central role in PRV host infection and pathogenesis, it would be pertinent to investigate 
a potential interference of gE with ERK1/2 signalling in neuronal cells, the further 
consequences on neuronal behaviour as well as the overall impact on PRV infection. 
 
gE (potential) receptor 
Another future step in our research would be to determine how gE is able to activate 
ERK1/2 via its extracellular domain. Based on literature and our preliminary data, there 
is a strong indication that the chemokine receptor CXCR4 is potentially involved in gE-
mediated ERK1/2 activation. 
To consolidate these findings, future experiments applying proteomic methods would 
be considered as a logical initial step. The most conventional method is protein isolation 
via Immunoprecipitation (IP). These isolations can be performed by either using 
antibodies against gE or CXCR4, or by tagging the interacting proteins of interest and 
using antibodies against the tag. While straightforward in concept, IPs can be 
challenging, relying on the strength of protein-protein interactions as well as on the 
affinity of the antibodies used for the isolations. An alternative approach for validating 
the gE-CXCR4 interaction is the assessment of potential co-localization of the proteins 
by immunofluorescence microscopy. Several optical techniques may serve as 
complementary or alternative approaches (Dunham et al., 2004). For example, Förster 
resonance energy transfer (FRET) and proximity ligation assay (PLA) can provide insight 
into direct interactions in situ.  
Chapter 5 – General Discussion 
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CONCLUDING NOTES 
Larger viruses often rely on multiple proteins that contribute to several aspects of 
survival of the virus within the host and/or population, such as host invasion and spread, 
immune evasion, host gene expression and virus transmission to other hosts. 
The main aim of this thesis was to further understand the biological functions of the 
alphaherpesvirus virulence factor gE and investigate its potential ability to interfere with 
host cell signalling. With our research, we discovered that gE manipulates a central 
cellular signalling network, the ERK1/2 signalling pathway, leading to a clear impact on 
downstream events, including changes in cellular behaviour. We are hopeful that our 
research could be the starting point for future investigations that may further unravel 
the importance of these findings and answer some of the questions that are still open, 
like confirming the role of CXCR4 and/or other putative cellular binding partners of gE in 
ERK1/2 signalling, exploring PRV/gE-mediated ERK1/2 manipulation in other relevant 
cellular models including neuronal cells, as well as during in vivo PRV pathogenesis. 
It remains extraordinary that viruses, via a limited set of viral proteins, can manipulate 
intricate and highly complex signalling networks to their advantage in multiple stages of 
the viral replication cycle, which likely is a result of strong evolutionary pressure in order 
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The glycoprotein E (gE), an envelope protein conserved amongst the Alphaherpesvirinae 
subfamily members, has been credited with multiple functions throughout the years. 
The role of gE in virulence, viral intercellular and neuronal spread, virion assembly, 
species-specific Fcγ receptor-like activity and antibody-induced capping has been 
reported by several authors, including our group.  
Herpesviruses are highly competent in manipulating cellular signalling cascades to their 
advantage. The ERK1/2 MAPK signalling pathway, a central signalling cascade, 
represents a particularly attractive target for viruses since this signalling axis controls 
various fundamental cellular events. Many herpesviruses have been reported to 
interfere with the ERK1/2 signalling pathway during different stages of the virus life 
cycle. 
In Chapter 1 we introduce pseudorabies virus (PRV) life cycle and pathology, and a 
description of the characteristics of gE and its role during PRV infection. We also describe 
the ERK1/2 signalling pathway and the involvement of this cascade in the cellular events 
relevant for this thesis, cell motility and cell survival. Finally, we provide an overview of 
studies that have shown the interaction/effect of different herpesviruses with the 
ERK1/2 signalling pathway. 
The main objective of the present thesis was to investigate whether PRV and particularly 
gE interfere with the ERK1/2 signalling machinery. Furthermore, we aimed at studying 
the biological effects resulting from PRV and gE’s interference with the ERK1/2 signalling 
pathway, which may contribute to viral replication and spread (Chapter 2). 
Immune evasion is one of the key elements to the success of herpesviruses propagation 
and survival in their hosts. We started by studying the effect of gE PRV on the ERK1/2 
signalling pathway in T lymphocytes (Chapter 3).  Since this signalling cascade is involved 
in key aspects of T cell activation, PRV may benefit from the modulation of this pathway 
as part of its virus immune evasion strategies. In Chapter 3a, we describe that PRV WT 
infection leads to the phosphorylation, and therefore activation of ERK1/2 in the Jurkat 
T cell line. Additionally, we observed that PRV interfered with ERK1/2 activation 
mediated by CD3/TCR signalling, the classical route used for T cell activation. These 
results suggest that, besides triggering ERK1/2 activation, PRV actively regulates the 
ERK1/2 cascade by blocking other external stimuli from activating ERK1/2. Going 





(PRVΔgE) did not cause ERK1/2 phosphorylation. Infection with a second isogenic PRV 
mutant lacking the cytoplasmic domain of gE (PRV gEΔcd), however, did not affect PRV-
mediated ERK1/2 activation. Taken together, these results show that PRV-induced 
ERK1/2 activation depends on gE, but does not require the cytoplasmic signalling 
domain of gE. To confirm that gE affects ERK1/2 phosphorylation through its 
extracellular domain, Jurkat T cells were incubated with a recombinant version of the 
extracellular domain of gE protein, which caused a rapid and transient activation of 
ERK1/2. 
To validate that PRV gE also leads to ERK1/2 activation in primary porcine T lymphocytes, 
we describe in Chapter 3b that, similarly to what was observed in Jurkat T cells, 
incubating primary T lymphocytes with recombinant gE led to a fast increase in ERK1/2 
phosphorylation. Additionally, two different experimental set-ups were used to 
corroborate these findings. In one set of experiments, swine testicle (ST) cells were 
transiently transfected with gE and co-cultured with primary T lymphocytes. In a second 
set of experiments, primary T lymphocytes were brought into contact with PRV WT or 
PRV ΔgE. These two experimental set-ups showed similar results: providing gE in trans 
to primary porcine T lymphocytes triggers a rapid and transient ERK1/2 activation. 
Primary porcine T lymphocytes have been shown, by us and other labs, to display limited 
susceptibility to productive PRV infection in vitro and in vivo. We co-cultured inoculated 
primary T lymphocytes with ST cells, which are highly susceptible to PRV infection. With 
this experiment, we confirmed earlier findings which have shown that apparently 
noninfected lymphocytes are able to transmit the virus to more virus-susceptible cells. 
However, gE (and therefore gE-induced ERK1/2 signalling) appears not to affect virus 
transmission from T cells to susceptible cells. Thus, we investigated whether the ability 
of PRV gE to trigger ERK1/2 activation would have any biological consequences on T 
lymphocyte behavior. Homotypic T cell aggregation correlates with T cell activation and 
formation of T cell aggregates upon contact with either infected cells or virus has been 
described before, albeit not in the context of herpesvirus infection. PRV WT caused an 
increase in T lymphocyte aggregation, whereas PRVΔgE was significantly impaired in 
triggering cell aggregation. As others before, we observed that T cell aggregation 
depends on ERK1/2 signalling, as the addition of an inhibitor of ERK1/2 signalling 
abrogated the formation of large cell aggregates. T cell aggregation has been described 
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to correlate with T cell migration. Inoculation of primary T lymphocytes with PRV 
resulted in an increased cell migration and, in line with our results on T cell aggregation, 
gE contributed to some extent to PRV-induced migration of T lymphocytes and inhibition 
of ERK1/2 signalling abrogated cell migration.  
ERK1/2 is not only involved in T cell activation, aggregation and motility, but also in 
promoting cell survival. Chapter 4 describes that PRV also causes ERK1/2 activation in 
epithelial cells. Infection of Porcine Kidney (PK15) cells with PRVΔgE further showed that 
gE is also involved in ERK1/2 phosphorylation in this cell type. We observed that PRV WT 
infection triggered degradation of the pro-apoptotic protein Bim and that this process 
was suppressed in PRVΔgE-infected cells. Addition of an ERK1/2 phosphorylation 
inhibitor during PRV WT infection fully prevented Bim degradation, confirming that PRV-
induced ERK1/2 activation results in Bim degradation. Interestingly, when PK15 cells 
were inoculated with PRV gEΔcd, we could observe a more rapid ERK1/2 
phosphorylation and a more dramatic Bim degradation that in PRV WT. This result may 
be explained by differences in gE cell surface expression, which clearly showed greater 
levels of gE in the plasma membrane of PRV gEΔcd-infected cells compared to cells 
infected with PRV WT cells. 
In Chapter 5 we discuss further our findings, highlighting hypothetical possibilities how 
this novel role of gE may contribute to survival and propagation of PRV within the host 
population, as well as its possible contribution to functions described in previous 
reports. Moreover, we discuss the mechanism via which gE may activate ERK1/2, as well 
as suggest CXCR4 as a putative binding partner for this glycoprotein. 
In conclusion, we describe for the first time that gE manipulates the cellular machinery 
of host cells by modulating the ERK1/2 signalling pathway in both T lymphocytes and 
epithelial cells. This leads to a clear impact on downstream events, such as changes in 
cellular behaviour like T cell activation and increased motility, or the interference with 
the apoptotic signalling network. We look forward for future research to further unravel 
the importance of these findings and answer pending questions including a further 
assessment of the role of CXCR4 and/or other putative cellular binding partners of gE in 
ERK1/2 signalling, exploring PRV/gE-mediated ERK1/2 manipulation in other relevant 


















Aan het glycoproteïne E (gE), een envelop eiwit dat geconserveerd is binnen de leden 
van de alfaherpesvirus subfamilie, werden over de jaren diverse functies toegewezen. 
Een rol van gE in virulentie, viraal intercellulair en neuronaal spreiden, virion vorming, 
species-specifieke Fcγ receptor activiteit en antistof-gemedieerde ‘capping’ werd 
gerapporteerd door diversie auteurs, inclusief door onze onderzoeksgroep.   
Herpesvirussen zijn zeer gedreven in het manipuleren van cellulaire signalisatiewegen 
voor hun eigen voordeel. De ERK1/2 MAPK signalisatieweg, een centrale 
signalisatiecascade, vormt een bijzonder aantrekkelijk doelwit voor virussen aangezien 
deze signalisatie-as diverse fundamentele cellulaire functies controleert. Voor veel 
herpesvirussen werd beschreven dat ze interfereren met  de ERK1/2 signalisatieweg 
tijdens verschillende stadia van hun virale vermeerderingscyclus.  
In Hoofdstuk 1 worden de vermeerderingscyclus en de pathologie van het pseudorabies 
virus (PRV) virus geïntroduceerd, en wordt een overzicht gegeven van de 
karakteristieken van het gE eiwit en zijn rol tijdens PRV infectie. Daarnaast wordt ook de 
ERK1/2 signalisatieweg beschreven en de betrokkenheid van deze cascade in cellulaire 
functies die relevant zijn voor deze thesis, namelijk celmotiliteit en het overleven van de 
cel. Finaal wordt een overzicht gegeven van de studies die een interactie/effect 
aangetoond hebben van verschillende herpesvirussen met/op de ERK1/2 
signalisatieweg. 
De belangrijkste doelstelling van deze thesis was om te onderzoeken of PRV, en in het 
bijzonder het gE eiwit, de ERK1/2 signalisatie moduleren. Daarnaast was een 
bijkomende doelstelling om enkele biologische effecten te onderzoeken die 
voortvloeien uit dergelijke modulatie van ERK1/2 signalisatie door PRV/gE en die een 
impact kunnen hebben op de vermeerdering en het spreiden van het virus (Hoofdstuk 
2). 
Immuno evasie is een sleutelelement in het succes van herpesvirus vermeerdering en 
persistentie in de gastheer. Daarom werd in eerste instantie het effect van PRV en gE op 
de ERK1/2 signalisatie onderzocht in een celpopulatie die van bijzonder belang is in de 
immuunrespons, de T lymfocyten (Hoofdstuk 3).  Aangezien deze signalisatieweg 
betrokken is in diverse aspecten van T cel activatie, is het mogelijk dat PRV deze 
signalisatie beïnvloedt als één van zijn immuno evasie mechanismen. In Hoofdstuk 3a 




ERK1/2 in de Jurkat T cellijn. Daarenboven werd aangetoond dat PRV de ERK1/2 activatie 
gemedieerd door CD3/TCR signalisatie, de klassieke weg voor T cel activatie, onderdrukt. 
Deze resultaten suggereren dat, naast het induceren van ERK1/2 activatie, PRV actief de 
klassieke ERK1/2 activatie via externe stimuli onderdrukt. In een volgende stap werd 
aangetoond dat een PRV virusmutant die geen gE tot expressie brengt (PRVΔgE) tijdens 
infectie van Jurkat T cellen geen aanleiding geeft tot ERK1/2 fosforylatie. Infectie met 
een andere isogene PRV mutant die enkel het cytoplasmatisch domein van gE mist (PRV 
gEΔcd) vertoonde daarentegen wel ERK1/2 fosforylatie. Deze resultaten tonen aan dat 
de PRV-geïnduceerde ERK1/2 activatie in Jurkat T cellen afhankelijk is van het gE eiwit, 
maar dat het cytoplasmatisch domein van dit eiwit hier niet bij betrokken is. Om te 
bevestigen dat het extracellulair gedeelte van het gE eiwit verantwoordelijk is voor de 
ERK1/2 fosforylatie werden Jurkat T cellen geïncubeerd met een recombinante versie 
van het extracellulair domein van gE, wat aanleiding gaf tot een snelle en tijdelijke 
activatie van ERK1/2.  
In Hoofdstuk 3b werd nagegaan of PRV gE ook aanleiding geeft tot ERK1/2 activatie in 
primaire porciene T lymfocyten. Hierbij werd aangetoond dat, net als bij Jurkat T cellen, 
incubatie van primaire porciene T lymfocyten met recombinant gE aanleiding gaf tot een 
snelle en tijdelijke ERK1/2 activatie.  Om deze bevindingen in primaire cellen te 
bevestigen werden twee bijkomende experimentele proefopzetten gebruikt. In één set 
van experimenten werden een ST (‘swine testicle’) epitheliale cellijn transiënt 
getransfecteerd met gE en in co-cultuur gebracht met primaire T lymfocyten. In een 
tweede reeks van experimenten werden primaire T lymfocyten in contact gebracht met 
PRV WT (wild type) of PRV ΔgE. Beide experimentele proefopzetten gaven een 
gelijkaardig resultaat: toedienen van gE in trans aan primaire porciene T lymfocyten gaf 
aanleiding tot een snelle en transiënte ERK1/2 activatie. Door onze en andere 
onderzoeksgroepen werd aangetoond dat primaire porciene T lymfocyten een zeer 
beperkte gevoeligheid hebben voor PRV infectie, zowel in vitro als in vivo. Wanneer we 
echter PRV-geïnoculeerde primaire T lymfocyten in co-cultivatie brachten met ST cellen, 
die zeer gevoelig zijn voor PRV infectie, konden we echter eerdere resultaten bevestigen 
dat schijnbaar niet-geïnfecteerde lymfocyten in staat zijn om het virus over te dragen 
naar meer virus-gevoelige cellen. Hierbij bleek dat gE (en dus gE-geïnduceerde ERK1/2 
activatie) niet rechtstreeks betrokken was bij de overdracht van het virus van de T cellen 
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naar de gevoelige cellen. Daarom werd onderzocht of het vermogen van PRV gE om 
ERK1/2 activatie te induceren mogelijks andere biologische gevolgen kon hebben op het 
gedrag van de T cellen, die mogelijks een impact kunnen hebben op het spreiden van 
het virus. In eerdere studies werd reeds aangetoond dat T cel aggregatie correleert met 
de activatie en migratie van T cellen. Voor andere virussen werd reeds aangetoond dat 
ze T cel aggregatie kunnen induceren, maar nog niet voor herpesvirussen. Wij konden 
aantonen dat PRV WT T cel aggregatie kan veroorzaken, terwijl PRVΔgE significant 
minder in staat was om dit proces te induceren. Zoals eerder  aangetoond in andere 
experimentele proefopzetten, konden we aantonen dat de T cel aggregatie afhankelijk 
is van ERK1/2 signalisatie, aangezien de toediening van een inhibitor van ERK1/2 
signalisatie het proces sterk onderdrukte. Eerder werd reeds aangetoond dat T cel 
aggregatie correleert met T cel migratie. In overeenstemming met de resultaten voor T 
cel aggregatie, konden we aantonen dat PRV WT de T cel migratie verhoogt, dat gE 
hiertoe tot op bepaalde hoogte bijdraagt en dat inhibitie van ERK1/2 signalisatie deze 
migratie verhindert. Daarenboven konden we aantonen dat de PRV-geïnoculeerde T 
cellen die migratie vertonen in staat zijn om het virus over te dragen naar gevoelige 
cellen. Alhoewel deze resultaten in vitro werden bekomen, suggereert dit dat PRV en 
gE-geïnduceerde, ERK1/2-afhankelijke T cel migratie kan bijdragen tot het efficiënt 
spreiden van het virus.  
ERK1/2 signalisatie is in veel meer processen betrokken dan enkel T cel activatie, 
aggregatie en motiliteit, waaronder in het verhinderen van apoptotische celdood. In 
Hoofdstuk 4 werd aangetoond dat PRV ook ERK1/2 activatie veroorzaakt in 
epitheelcellen. Infectie van de epitheliale PK15 (‘porcine kidney’) cellijn met PRV WT of 
PRVΔgE toonde aan dat PRV ook in dit celtype ERK1/2 fosforylatie induceert, en dat ook 
hier het gE eiwit hierbij belangrijk is. Daarenboven leidde PRV WT infectie in deze cellen 
tot afbraak van het pro-apoptotische eiwit Bim en deze degradatie was onderdrukt in 
cellen geïnfecteerd met PRVΔgE. Toediening van een ERK1/2 fosforylatie inhibitor 
verhinderde Bim degradatie tijdens PRV WT infectie volledig, wat dus aanduidt dat PRV-
geïnduceerde ERK1/2 activatie aanleiding geeft tot Bim degradatie in PK15 cellen. 
Interessant hierbij was dat infectie van PK15 cellen met de PRV gEΔcd virusmutant, die 
dus het cytoplasmatisch domein van gE mist, aanleiding gaf tot een snellere ERK1/2 




resultaat kan verklaard worden door het feit dat deze virusmutant sneller grotere 
hoeveelheden van het gE eiwit tot expressie brengt in de plasmamembraan van de 
geïnfecteerde cel, in vergelijking met PRV WT.  
In Hoofdstuk 5 worden de bevindingen van deze thesis bediscussieerd, waarbij nadruk 
gelegd wordt op hypothetische mogelijkheden hoe deze nieuwe rol van het virale gE 
eiwit mogelijks kan bijdragen tot het persisteren en vermeerderen van PRV in de 
gastheer populatie, en hoe deze nieuwe rol kan bijdragen tot functies die eerder werden 
beschreven voor gE. Daarenboven worden de mechanismen bediscussieerd hoe gE 
aanleiding kan geven tot ERK1/2 activatie, waarbij de mogelijke rol van de cellulaire 
chemokine receptor CXCR4, als mogelijke receptor voor gE, besproken wordt.  
Samengevat kan gesteld worden dat in deze thesis voor de eerste maal werd 
aangetoond dat gE de cellulaire machinerie van gastheer cellen beïnvloedt door 
modulatie van de ERK1/2 signalisatieweg, en dit zowel in T lymfocyten als epitheelcellen. 
Het activeren van deze signalisatieweg heeft duidelijke biologische consequenties, 
waaronder veranderingen in cellulair gedrag zoals T cel aggregatie en motiliteit en 
interferentie met de signalisatie die aanleiding geeft tot apoptotische celdood. We 
kijken uit naar toekomstige experimenten die het belang van deze bevindingen verder 
zullen onderzoeken en antwoord zullen proberen te bieden op diverse openstaande 
vragen zoals de rol van CXCR4 en eventueel andere potentiële bindingspartners van gE 
in ERK1/2 signalisatie, het voorkomen en effect van PRV/gE-gemedieerde ERK1/2 
manipulatie in andere relevante cellulaire modellen waaronder neuronale cellen, en het 
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